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Tekijä — Författare — Author  
Alli Hietikko 
Työn nimi — Arbetets titel — Title  
Characterization of Pseudomonas aeruginosa phages for phage therapy 
  
Työn laji — Arbetets art — Level 
Master’s Thesis  
Aika — Datum — Month and year  
April 2019 
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INTRODUCTION  
Pseudomonas aeruginosa is a gram-negative, opportunistic pathogen occurring in the human 
intestine, on the skin, and in the environment. P. aeruginosa is pathogenic to humans only when 
introduced to an area lacking a natural defense mechanism or when a person’s defenses are 
impaired due to an illness. Infection is often produced in damaged tissue such as wounds or burns 
[1],  in the urinary tract after catheter introduction [2], or as a chronic respiratory infection in cystic 
fibrosis patients [3]. In addition, P. aeruginosa may in the most extreme cases cause fatal sepsis 
when invading the bloodstream. Among other Pseudomonas species, P. aeruginosa is naturally 
resistant to many antimicrobial agents [4] as well as to the immune system due to its biofilm 
formation [5,6]. 
Multidrug resistance of P. aeruginosa is occurring primarily in cystic fibrosis patients and patients 
hospitalized in intensive care units, and the proportion of isolates resistant to multiple drugs is rising 
rapidly [7]. The excessive use of antibiotics and the halt in the development of new antimicrobial 
drugs has caused the rise of antibiotic-resistance in bacteria and the selection for resistance genes 
[8].  
Alternative ways to cure infections caused by antibiotic-resistant bacteria are being developed to 
replace or act alongside antibiotics. Phage therapy, a method which utilizes bacterial viruses 
(bacteriophages) to kill specific infectious bacteria, presents one possible way to battle the global 
threat caused by the spreading of antimicrobial-resistance [9,10]. Lytic phages lyse the bacterial cell 
at the end of their infection cycle, therefore killing the bacteria. This event lays the foundation for 
phage therapy [11]. The phages used for therapeutic purposes must meet strict criteria to be 
deemed safe to use. In addition to being free of any toxin or antibiotic-resistance coding genes they 
must be virulent, unable of lysogenic conversion [12]. A lysogenic phage integrates its genome into 
the host’s chromosome becoming a prophage [11], usually making the host phage-resistant [11,12]. 
Lysogenic phages may convert back to a lytic cycle in certain conditions, but as a prophage, they do 
not cause cell lysis and thus would be ineffective in phage therapy [11]. Identifying lysogenic phages 
can often be carried out with genomic analysis, as the genomes of lysogenic phages usually code 
integrases, transposases or lytic phage repressors [13]. 
Over 94% of the known Pseudomonas phages found in the National Center for Biotechnology 
Information (NCBI) database are classified in three families of the Caudovirales order: Podoviridae, 
Siphoviridae, and Myoviridae with genome sizes ranging from 3.6 kb to 320 kb [14,15]. All phages in 
the order are double-stranded DNA viruses with differing tail structures, and approximately 60% of 
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them are lytic. The genome size is generally larger in Myoviridae than in Podoviridae or Siphoviridae, 
ranging from 64 kb to ~310 kb, whereas in the other two the size usually falls under 80 kb. It is 
characteristic of the phages in the Myoviridae family to have a long tail that contracts upon the 
phage injecting its genome into the host cell. [16] 
This work aimed to study the genomic properties of four P. aeruginosa phages, in order to verify 
them safe to use for therapeutic purposes within the range of current knowledge. Additional 
experiments were conducted to determine the capsid structure and infection characteristics of one 
of the phages, vB_PaeM_fHoPae01 (fHo-Pae01, GenBank: MK318076.1), as it is a recent isolate of 
the Skurnik group. 
 
MATERIALS AND METHODS 
Phages, bacterial strains and growth conditions  
All bacterial strains used in laboratory work were clinical Pseudomonas aeruginosa strains (HUSLAB, 
[17]) (Table S1). 
The fHo-Pae01 phage was previously isolated in the Skurnik group by Tommi Patinen [18]. P. 
aeruginosa #5525 (HUSLAB) [18] was used as the standard host for this phage. Phages PA1P1, PA8P1 
and PA11P1 were isolated elsewhere [17]. The standard hosts used were P. aeruginosa PA1 for 
PA1P1, PA8 for PA8P1, and PA11 for PA11P1 [17]. 
The bacterial cultures and phages were incubated at +37 qC using Luria broth (LB) liquid medium or 
soft agar medium (0.4% (w/v) agar) solidified on LB agar plates (1.5% (w/v) agar) [19]. The phage 
lysates were prepared from semiconfluent soft agar plates with the host bacteria from a culture 
incubated until the logarithmic growth phase. The amount of bacterial culture added was calculated 
from the equation: 25.5μl OD600-1.  The same equation was used for the amount of bacterial culture 
when titrating phages on double layer plates [19]. 
 
In silico analysis of phage genomes 
All phage genomes had previously been sequenced by next-generation sequencing (Eurofins GATC), 
assemblies of the over 12 million reads per genome had been made, and the contigs containing the 
phage genomes had been identified. In this work, PhageTerm program [20] was used to estimate 
the genome origins and packaging methods of the phages. The genomes were managed with 
Geneious 11.1.5 (https://www.geneious.com). The assembled genomes were also aligned in 
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Geneious 11.1.5 (https://www.geneious.com) with the original reads to ensure no mistakes were 
made in the assembly. 
The preliminary annotations were automatically carried out with RAST 2.0 (Rapid Annotation using 
Subsystem Technology) [21-23]. Glimmer3 software [24,25] was used to make corrections to the 
annotations formed by RAST 2.0 [21-23]. Based on the RAST 2.0 [21-23] and Glimmer3 [24,25] 
results, the final, more detailed annotations were performed with BLASTp (Protein Basic Local 
Alignment Search Tool) [26], and the results were manually evaluated.  
The phage genomes were screened for tRNA (tRNAscan-SE 2.0 [27], Aragorn [28]), virulence 
(VirulenceFinder 2.0 [29]), and antibiotic-resistance genes (ResFinder 3.1 [30]). 
A comparative alignment between the phage genomes and the type phage PB1 (GenBank: 
NC_011810.1) genome was conducted with Geneious 11.1.5 (https://www.geneious.com), 
Geneious alignment tool. 
A phylogenetic tree was constructed with VICTOR software (Virus Classification and Tree Building 
Online Resource) [31] using Genome-BLAST Distance Phylogeny (GBDP) method. Genome-wide 
BLASTN runs were performed to the four phages and the type phage PB1. 22 of the best matches 
(query cover >90%) were chosen for the tree (Table S2). The open reading frame (ORF) of the first 
predicted gene in fHo-Pae01, FHP001, was identified in all phage genomes used for the tree. All the 
genomes were then set to start from that ORF, to yield a more reliable phylogenetic tree. 
A protein corresponding to a predicted tail fiber protein (GenBank: BAU20669.1) of Pseudomonas 
phage KPP22 (GenBank: LC105987.1), assumed to affect the adsorption of the phage to the host cell 
[32], was identified in the genomes of fHo-Pae01 (FHP062), PA1P1 (PA1P1_063), PA8P1 
(PA8P1_062), and PA11P1 (PA11P1_062). The amino acid sequences of the predicted tail fiber 
proteins in fHo-Pae01, PA1P1, PA8P1, and PA11P1 were aligned with Clustal Omega 1.2.4 [33]. 
 
Host range screening 
The host ranges for all four phages were screened with the 47 clinical, antibiotic-resistant P. 
aeruginosa strains available (Table S1). Screenings were performed in liquid cultures on a 96-well 
plate over 6 hours, by measuring the absorbance at 595 nm (Hidex Plate CHAMELEON Multilabel 
Detection Platform) at 60 min intervals. In each well, 190 Pl of 1:40 dilution of the host bacteria 
overnight culture was mixed with 10 Pl lysate (109 pfu/ml) of one of the phages. Wells with LB 
medium replacing the phage lysate were used as negative controls. As positive control, each phage 
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was also used to infect its standard host. The host range liquid culture screening method had 
previously been tested (Schaedig et al., unpublished results) to yield results comparable to the more 
commonly used plating method [34].  
 
One-step growth curve 
The standard host of the phage fHo-Pae01, P. aeruginosa #5525, was incubated in 10 ml LB medium 
until the absorbance, measured with Cell density meter DSM-Micro (Laxco) at 600 nm was 0.4 – 0.5. 
The phage was added to reach an MOI value of 0.0005 to ensure no more than one phage would 
infect a single host cell. A 150 Pl sample at 0 min was taken immediately. The sample was treated 
by first harvesting the cells by centrifugation for 1 min at 11,000 x g. Then, the supernatant was 
discarded and replaced by fresh media so that only the phages adsorbed on the surface or inside 
the cells were taken into account. The sample was then titrated. 
The phages were left to adsorb for 15 min with light shaking, after which the cells were harvested 
by centrifugation for 5 min at 4,500 x g, and the media was replaced to produce a synchronized 
infection. A dilution series was prepared until 10-3 in 10 ml LB medium. The incubation was 
continued, and 20 – 50 Pl samples titrated every 10 – 30 min.  
The growth curve was calculated using the mean values of three separate experiments by assigning 
the value 1 to correspond the phage titer at 0 min. [35,36]  
 
Phage purification with anion-exchange chromatography 
The phage lysate was concentrated to a volume of 1 ml and changed to buffer A (20 mM Tris-Cl, pH 
8.5) by ultrafiltration with a Vivaspin 6 (100 kDa) centrifugal PES membrane concentrator 
(Sartorius). The sample was then filtered through a 0.2 µm pore filter. The anion-exchange 
chromatography was performed with Äkta Purifier (GE Healthcare), and a CIMmultus QA-1 tube 
advanced composite column with a 6-µm pore size (BIA Separations). The high pH of 8.5 for the 
buffers was selected to ensure the negative charge of the major capsid protein. The isoelectric point 
of the putative major structural protein of fHo-Pae01, FHP_041, was determined using EMBOSS 
Pepstats software [37]. 
A linear gradient purification was made to determine the conditions for the two-step purification. 
The sample was injected to the column in buffer A, and the phage was eluted with buffer A and with 
a 0 mM – 550 mM gradient of NaCl. (Fig. S2) 
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In the step purification, the sample was injected to the column in buffer A, the column was washed 
with buffer A with 160 mM NaCl, and the phage was eluted with buffer A with 350 mM NaCl. The 
two fractions containing the phage were pooled, and the buffer was changed to gelatin-free SM 
buffer (100 mM NaCl, 10 mM MgSO4, 50mM Tris-HCl, pH 7.5) with a Vivaspin 6 centrifugal 
concentrator. (Fig. S3) 
 
Atomic force microscopy 
The purified phage was imaged a multimode 8 AFM connected to a Nanoscope V controller (Bruker). 
The images were taken in tapping mode in the air with an E scanner using NCHV-A probes (Bruker 
AFM probes). The images were taken at Aalto University, Department of Bioproducts and 
Biosystems. 
 
RESULTS 
Genome analyses 
The genomic sequences of PA1P1, PA8P1, and PA11P1 were sequenced previously. PhageTerm [20] 
software was then used to determine the physical ends of the pre-assembled genomes. A headful 
packaging mechanism was predicted by the program as the method used by all three phages to 
package their genome into the phage capsid. The mechanism does not have a specific cleaving site 
for the C terminal end of the genome, but rather cleaves the DNA strand once the virion head is full, 
resulting in genomes of varying lengths in individual phage particles [38,39]. The annotation and 
PhageTerm analysis of fHo-Pae01 was done by Pulkkinen et al. (manuscript under preparation). 
All four phage genomes – fHo-Pae01, PA1P1, PA8P1, and PA11P1 – were similar in length (65 – 67 
kbp) and GC content (55 – 56%). Furthermore, the number of predicted genes was 92 – 93 in all 
genomes, of which 66 – 67 were hypothetical proteins with unknown functions (Tables S3 – S6). The 
scans performed using tRNAscan-SE 2.0 [27], and Aragorn [28] found no transfer RNA coding genes. 
The phages were expected to be strictly lytic as no lysogeny-associated genes or integrases were 
identified. Additionally, no virulence-associated, toxic or antibiotic-resistance genes were 
recognized in any of the four genomes. (Table 1) 
All genomic sequences were constructed using over 12 million sequencing reads. The genomes were 
aligned with the original reads to find mistakes made during the assembly. One uncertain 
sequencing result was found in all four genomes: a 9 – 10 bp guanine repeat in PA1P1_61A, 
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PA8P1_60A, and PA11P1_60A, and in between the predicted genes FHP_059 and FHP_060 in fHo-
Pae01. The length of the repeat was nine bp in approximately half of the reads and ten bp in the 
other half. The final sequences have the sequence with nine guanine nucleotides in accordance to 
the sequence of PB1. The sequencing method may not have been sensitive enough to reliably be 
able to determine the length of unusually long one-nucleotide repeats.  
 
Comparative genome analysis 
Altogether, the genomes of fHo-Pae01, PA1P1, PA8P1, and PA11P1 were highly similar, sharing over 
90% identities with each other, and 85 – 86% with the Pbunavirus type phage PB1 (Table 1). The 
pattern of predicted genes is also highly similar in all four phages and the type phage (Fig. 1) with 
the most significant differences described in Table 2.  
The phylogenetic tree (Fig. 2) clustered the 27 phage genomes as seven species, all belonging to the 
Pbunavirus genus and Myoviridae family. The phages fHo-Pae01, PA1P1, PA8P1, and PA11P1, were 
classified as the same species as Pseudomonas phages 14_1, JG024, NP3, PII10A, SL1, and SN rather 
than the Pbunavirus type phage PB1.  
Table 1: Statistic of fHo-Pae01, PA1P1, PA8P1, PA11P1, and the type phage PB1 genome analyses. Number of 
predicted genes and hypothetical proteins, GC content, genome length, and sequence identities of the phage genomes 
with each other.  
 
fHo-Pae01 PA1P1 PA8P1 PA11P1 PB1 
Genome length (bp) 66,418  66,612  65,690  66,049  65,764 
Predicted genes 92 93 92 92 94 
Hypothetical proteins 66 67 67 67 80 
GC% 55.7 55.8 55.7 55.7 54.9 
Identity with fHo-Pae01 (%) 100 94.8 93.5 94.3 86.1 
Identity with PA1P1 (%) 94.8 100 94.8 97.1 86.3 
Identity with PA8P1 (%) 93.5 94.8 100 96.4 85.5 
Identity with PA11P1 (%) 94.3 97.1 96.4 100 85.1 
All statistics were calculated using Geneious 11.1.5 (https://www.geneious.com). 
  
 
 
 
 
Fig. 1. A genome-wide alignment created with Geneious 11.1.5 (https://www.geneious.com) software of the fHo-Pae01 (GenBank: MK318076.1), PA1P1, PA8P1, PA11P1 and PB1 (GenBank: 
NC_011810.1) phage genomes. The predicted genes are marked in yellow. The height and color of the identity bar indicates the mean pairwise identity over all pairs in the column (Green: 100% 
identity, yellow: 30% - 100% identity, red: below 30% identity). The PB1 type phage shared an overall 85-86% identity with the other phage genomes. The identities among phages fHo-Pae01, 
PA1P1, PA8P1 and PA11P1 were even higher: 93-97%. The genome of PB1 was adjusted to originate from the gene corresponding to the first predicted gene in the other phage genomes.
Table 2: Major differences in the predicted genes of fHo-Pae01, PA1P1, PA8P1, PA11P1, and PB1.  
fHo-
Pae01 
PA1P1 PA8P1 PA11P1 PB1 Description of the differences 
FHP_003c PA1P1_003c PA8P1_003c PA11P1_003c PB1_gp81 
PA1P1_003c, PA8P1_003c and PA11P1_003c are 
identical. FHP_003c and PB1_gp81 are similar to 
the previous three and to each other. 
FHP_006c PA1P1_006c no seq PA11P1_006c no seq  
no seq PA1P1_011c no seq no seq PB1_gp88  
FHP_013c PA1P1_014c PA8P1_012c PA11P1_013c 
PB1_gp91, 
PB1_gp92 
PB1_gp91 is a different protein than PB1_gp92, and 
both are different proteins than the others shown. 
FHP_013c is similar to PA1P1_014c. 
FHP_015c PA1P1_016c PA8P1_014c PA11P1_015c PB1_gp94 
PA8P1_014c and PA11P1_015c are identical but a 
different protein from the others shown. PB1_gp94 
is approximately 90 amino acid residues shorter 
than FHP_015c and PA1P1_016c. 
no ORF PA1P1_018c PA8P1_016c PA11P1_017c PB1_gp02 
PB1_gp02 is a different protein from the others. A 
mutation in fHo-Pae01 leading to frameshift has 
caused a stop codon in the region. 
FHP_017c PA1P1_019c PA8P1_017c PA11P1_018c PB1_gp03 PB1_gp03 is a different protein from the others. 
no ORF no ORF PA8P1_018 no ORF no ORF 
Glimmer3 found a gene in this region of fHo-Pae01 
and PA8P1. The gene predicted in fHo-Pae01 is 
similar to PA8P1_018, but it has not been 
annotated. 
FHP_026c PA1P1_028c PA8P1_027c PA11P1_027c no ORF 
Glimmer3 predicted a similar gene in PB1, but it has 
not been annotated. FHP_026c and PA1P1_030c 
are similar to the others shown and to one another. 
FHP_028c PA1P1_030c PA8P1_029c PA11P1_029c no seq  
FHP_029 PA1P1_031c PA8P1_030c PA11P1_030c PB1_gp13 
PB1_gp13 is approximately 55 amino acid residues 
longer than the others shown, has a different 
predicted start codon, and is similar to 
PA1P1_031c, PA8P1_030c, and PA11P1_030c. 
FHP_029 is a different protein from the others 
shown. 
FHP_038 no ORF no ORF no ORF no ORF 
Glimmer3 did not predict any genes. The DNA 
sequence has premature stop codons in all but 
FHP_038. 
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FHP_084c PA1P1_085c PA8P1_084c PA11P1_084c PB1_gp69 
PA8P1_084c and PB1_gp69 are identical. The 
others are similar to them and to one another. 
FHP_088 PA1P1_089 PA8P1_088 PA11P1_088 PB1_gp73 
PA8P1_088 and PB1_gp73 are different proteins 
from the others and from one another. PA1P1_089 
and PA11P1_088 are identical, and FHP_088 is 
similar to them. 
 
Glimmer3 [24,25] and BLASTp [26] software were used to verify some of the genes predicted by RAST 2.0 [21-23]. No seq: 
a gap in the sequence on the site of the predicted gene. No ORF: no annotated predicted gene on the site. Identical: 95 
– 100% pairwise amino acid identity. Similar: 60 – 95% pairwise amino acid identity. Low amino acid identity: 45 – 60% 
pairwise amino acid identity. Different protein: less than 45% pairwise amino acid identity. 
 
 
Fig. 2. A phylogenetic tree of the 17 closest BLASTn matches to the fHo-Pae01, PA1P1, PA8P1, and PA11P1 phage 
genomes (highlighted in yellow) and 5 closest BLASTn matches to the type phage PB1 phage genome. The tree was 
constructed with VICTOR (Virus Classification and Tree Building Online Resource) [31]. All of the genomes in the tree 
belong to Pbunavirus genus of the Myoviridae family. The genomes were clustered in 7 species. The phages fHo-Pae01, 
PA1P1, PA8P1 and PA11P1 are classified as the same species as Pseudomonas phages 14_1, JG024, NP3, PII10A, SL1, and 
SN, rather than Pseudomonas phage PB1 which is the type phage of the genus. S: species, G: genus, F: family. 
 
Infection cycle 
A one-step growth curve experiment was conducted to fHo-Pae01 to determine the number of new 
phage progenies released by a single infected bacterial cell (burst size), as well as the duration of 
the latent period, i.e., the time from infection to the beginning of cell lysis. The latent period was 
determined to be 70 minutes long. However, the four repeated experiments deviated substantially 
from one another later during the infection cycle. Thus, the burst size could not be determined. 
 13 
Experiments with longer incubation time did not reveal a new latent period (data not shown). (Fig. 
3) 
 
Host range 
The host ranges of all four phages were assessed using 47 clinical P. aeruginosa strains (Table S7, 
Fig. S1). Of the four phages, fHo-Pae01 had the narrowest specificity, infecting only 14 clinical strains 
(30%). PA1P1 infected 33 (70%), PA8P1 infected 24 (51%) and, PA11P1 infected 31 (66%) of the 
strains. A comparative alignment of the possible host receptor recognizing tail fiber proteins was 
performed to elucidate the differences in host specificities. According to the alignment (Fig. 4), the 
predicted tail proteins PA1P1_063 and PA11P1_062 were 100.00% identical. Moreover, PA8P1_062 
was 97.40% identical to PA1P1_063 and PA11P1_062. However, the tail fiber protein of fHo-Pae01, 
FHP062, shared a sequence identity of 82.40% with PA1P1_063 and PA11P1_062, and 84.06% with 
PA8P1_062. The variation between FHP062 and the others was concentrated in the C termini of the 
proteins with a pairwise identity of 54.0% in A670 – A963 determined by Geneious 11.1.5. 
 
Fig. 3: One-step growth curve of phage fHo-Pae01 in its standard host P. aeruginosa 
#5525 as PFU per infected cell at different timepoints. The data points are averages of 
four experiments at time points 70 minutes, 90 minutes, and 110 minutes, and of three 
experiments for the other timepoints. The latent period was 70 minutes. The variation 
between the experiments did not allow for a reliable estimation of the burst size. 
0.0
20.0
40.0
60.0
80.0
100.0
120.0
140.0
160.0
0 20 40 60 80 100 120 140
PF
U 
pe
r i
nf
ec
te
d 
ce
ll
Time after infection (min)
 14 
 
 
Fig. 4. An alignment of the putative host recognizing tail proteins of fHo-Pae01, PA1P1, PA8P1, and PA11P1. Created 
with Geneious 11.1.5 (https://www.geneious.com) software. The height and color of the identity bar indicates the mean 
pairwise identity over all pairs in the column (Green: 100% identity, yellow: 30% - 100% identity, red: below 30% identity). 
PA1P1_063 and PA11P1_062 are 100.00% identical. PA8P1_062 is 97.40% identical to the latter, with mutations spread 
evenly along the length of the protein. FHP_062 is 84.06% identical to PA8P1_062, and 82.40% identical to PA1P1_063 
and PA11P1_062. The differences between FHP_062 and the others are concentrated on the C terminal end of the 
protein.  
 
Purification of phage fHo-Pae01 
The phage fHo-Pae01 was purified for atomic force microscopy using anion-exchange 
chromatography by determining the conditions for a step-gradient purification with a linear-
gradient run (Fig. S2) before performing the step-gradient run (Fig. S3). The isoelectric point of the 
putative major structural protein, as determined by EMBOSS Pepstats [37] was 5.8560. The pH 8.5 
of the buffers was chosen based on  the isoelectric point and a previous unsuccessful purification 
with pH 7.0 (Patinen et al. unpublished results). 
The amount of phage injected into the column in the step gradient purification, 1.7 u 1011 pfu, was 
determined by the titer of the lysate as measured before changing the buffer, filtration, or 
concentration of the sample. The purified phage yield was 5.7 u 109 pfu, and the final yield after 
changing the buffer was 4.7 u 109 pfu. Thus, the yield of purified phage was approximately 2.8% of 
the amount that was injected into the column, though a portion of the phages may have been lost 
during the sample preparation steps before injection. 
 
Imaging 
Atomic force microscopy was used to image the fHo-Pae01 virus particle. However, the resolution 
of the microscope was not optimized for biological samples. Although the objects in the images 
resemble bacteriophages by shape, no reliable conclusions can be made of them. (Fig. 5) 
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Fig. 5. Image of the purified fHo-Pae01 phage particle taken using atomic force microscopy. Although some particles 
resembling phages (indicated with red circles) could be found, the resolution of the microscope did not allow any 
conclusions to be made of the particle. 
 
DISCUSSION 
This study reports the fully annotated DNA sequences and infection characteristics of P. aeruginosa 
phages PA1P1, PA8P1 and PA11P1 as well as a new phage fHo-Pae01, isolated in the Skurnik group. 
All studied phages were predicted to belong to the same species with Pseudomonas phages 14_1, 
JG024, NP3, PII10A, SL1, and SN of the Pbunavirus genus, but to a different species than the 
reference phage PB1. The phages all had genomes of 65 – 67 kbp. The small genome size is 
characteristic of Pbunaviruses unlike in many other members of the Myoviridae family [16]. The 
atomic force microscopy failed to produce further insight on the morphology of fHo-Pae01. This 
method of imaging phages has previously shown some promising results [40,41], but the atomic 
force microscope used may not have met the necessary standards for imaging particles on the 
nanometer scale. The phage has since been imaged by transmission electron microscopy (Pulkkinen 
et al., manuscript under preparation), but that is beyond the scope of this thesis. 
No tRNA-coding genes were identified, which indicates that phages are dependent on the host tRNA 
molecules and may use codon-optimization to exploit the translation machinery of the host [42]. 
Additionally, all four phages were concluded to likely be harmless to humans, as no potential 
virulence-associated, toxic, or antibiotic resistance genes were recognized. Moreover, no genes 
associated with a temperate infection cycle were identified, so all of the phages are assumed to be 
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strictly lytic. Still, more than 70% of the annotated genes had unknown functions, which is typical of 
bacteriophages (NCBI database) and demonstrates how much is still unknown about bacterial 
viruses. The annotated genomes of PA1P1, PA8P1, and PA11P1 will be submitted to the GenBank 
database shortly.  
The GC content of approximately 56% in the studied phage genomes was similar to many other PB1-
like P. aeruginosa phages [43]. Often, the phage and host genomes are similar in GC content. 
However, it is common for P. aeruginosa phages to have a significantly lower GC content compared 
to the bacterial host [44]. No sequencing data of the bacterial hosts used in this study was available, 
but 186 of the 187 complete P. aeruginosa bacterial genomes on the NCBI database had a GC 
content of 65.08 – 66.84%.  Therefore, these phages likely exhibit a similar difference in GC content 
to their hosts (approximately 10 percentage points lower) as previously reported for other P. 
aeruginosa phages [43].  
The G-rich nucleotide sequence observed in all four phage genomes is a common feature of PB1-
like phages, as this stretch has been predicted to be a site for ribosomal frameshift [43]. This may 
also to be the case for the four phages studied here. It is possible that the slippery sequence of the 
repeated G nucleotide enables multiple proteins to be translated from the same mRNA sequence, 
depending on ribosomal frameshifts. Assuming the G repeat is nine nucleotides long in reality, a +1 
frameshift is likely to take place, which would yield a merged form of PA1P1_061A and PA1P1_061B. 
In this case the same would be true for PA8P1_060A and PA8P1_060B as well as PA11P1_060A and 
PA11P1_060B. 
 A +1 shift is known to be common in dsDNA phages and has been well documented in many phages 
across multiple host organisms [45-47]. If a -1 frameshift took place on this site, a stop codon would 
form before the origin of the PA1P1_061B (PA8P1_060B, PA11P1_060B) gene. Thus, two proteins 
originating from the same site may be produced: a short protein with no ribosomal frameshift 
(PA1P1_061A, PA8P1_060A, PA11P1_060A), and a longer protein caused by a +1 frameshift 
(PA1P1_061A + PA1P1_061B, PA8P1_060A + PA8P1_060B, PA11P1_060A + PA11P1_060B). It would 
be interesting to analyze the protein production in an infected cell to find out which frameshift could 
be observed in vivo, and in what ratios the different products of this site are produced. Previous 
studies would suggest the shorter product with no frameshift to be the major product [46-48]. 
Of the four phages studied, PA1P1 and PA11P1 are the most promising candidates to be used for 
phage therapy as their host ranges are the broadest. This is a desirable property, as it indicates a 
higher probability of the phage being able to infect new host strains. Here, the tail fiber protein 
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predicted to mediate the adsorption of the phage to the host cell somewhat correlated with the 
observed host ranges. However, I assume this protein not to be the only factor mediating the phage 
attachment to its receptor as PA1P1_063 and PA11P1_062 were 100.00% identical, yet their host 
ranges differed marginally. 
Phages are often applied as a cocktail, a mixture of two or more phages infecting the same host, to 
prevent the development of phage resistance and to improve the efficiency of the treatment 
[49,50]. For this purpose, phages with the widest host ranges are chosen to produce the broadest 
lytic range possible for the final cocktail. Therefore, it is exceedingly important for the establishment 
of efficient phage therapy to discover multiple phages infecting the same host species of bacteria. 
Phage resistance for therapy products develops when the receptor of the host bacteria is lost or 
mutated [11], so phages utilizing differing receptors should be prioritized. For that reason, it would 
be beneficial to determine the receptors of the phages in future studies. Often, phage receptors 
such as lipopolysaccharides also act as virulence factors. The mutations leading to phage resistance 
in these structures may even be beneficial, making the pathogen less virulent and more susceptible 
to the immune system [11]. 
The one-step growth curve characterizing the infection cycle of fHo-Pae01 revealed the latent 
period to be 70 minutes long. This result deviates from the 35 – 50 minutes previously reported for 
most PB1-like phages [35,51,52]. It has been documented that longer latent periods correlate with 
higher burst sizes at the lysis [53,54]. This is due to the phage having more time to utilize the  
resources of the host [53]. Thus, it would be reasonable to expect a large burst size in relation to 
other PB1-like phages. The optimization of the one-step growth curve method will be continued to 
determine the burst size of fHo-Pae01, although it is beyond the scope of this thesis. I hypothesize 
that the 15 minute adsorption time used before for Pseudomonas phage JG024 [35] was too long to 
produce a sufficiently synchronized infection for fHo-Pae01.  
The optimization of the purification conditions must also be continued. When purifying the fHo-
Pae01 phage with anion-exchange chromatography, a significant number of the phages were lost, 
presumably caused by the weak attachment of the phage to the column. The yield 2.8% was merely 
a fraction of the >70% achieved for other phages in the Skurnik group. The bond could be tightened 
by raising the pH of the buffers used, but this would likely denature the phage capsids and render 
them unviable. For therapeutic use, an alternative approach for purification should be used. 
Promising results have recently been achieved by combining ultrafiltration with commercial 
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endotoxin binding columns. This method may even be faster and more efficient in separating 
bacterial LPS from the phage lysate than many of the other commonly used methods [55].   
In conclusion, no indication of genes encoding antibiotic-resistance, toxins or lysogeny-associated 
was observed, suggesting the four phages – fHo-Pae01, PA1P1, PA8P1, and PA11P1 – to be 
potentially safe to use in phage therapy to treat P. aeruginosa infections and in other possible 
applications such as biofilm prevention. The wide host ranges of PA1P1 and PA11P1 make them the 
most compelling candidates for treatment. In the future, clinical studies should be carried out to 
determine the in vivo efficiency of these phages in curing infections. 
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Table S1: Pseudomonas aeruginosa strains used in laboratory work 
Pseudomonas aeruginosa strain 
access number in Skurnik lab 
Official 
name 
Notes Reference/origin 
5513   HUSLAB 
5514   HUSLAB 
5525   HUSLAB 
5537   HUSLAB 
5538  MDR HUSLAB 
5539  MDR HUSLAB 
5548   HUSLAB 
5550   HUSLAB 
5551   HUSLAB 
5553   HUSLAB 
5668   HUSLAB 
5669   HUSLAB 
5670   HUSLAB 
5671   HUSLAB 
5672   HUSLAB 
5740   HUSLAB 
5741   HUSLAB 
5742   HUSLAB 
5743   HUSLAB 
5745   HUSLAB 
5746   HUSLAB 
5747   HUSLAB 
5826   HUSLAB 
5827  MDR HUSLAB 
5828   HUSLAB 
5829   HUSLAB 
5831   HUSLAB 
5832   HUSLAB 
5833  MDR HUSLAB 
5834  MDR HUSLAB 
5835   HUSLAB 
5836   HUSLAB 
5837   HUSLAB 
5838   HUSLAB 
5839   HUSLAB 
5840   HUSLAB 
5841   HUSLAB 
5842  MDR HUSLAB 
5844  MDR HUSLAB 
5845   HUSLAB 
5846   HUSLAB 
5847   HUSLAB 
5848   HUSLAB 
6327 PA1  (Mattila, Ruotsalainen & Jalasvuori 2015) 
6329 PA8  (Mattila, Ruotsalainen & Jalasvuori 2015) 
6331 PA11  (Mattila, Ruotsalainen & Jalasvuori 2015) 
6663   HUSLAB 
According to the GDPR law, official strain codes must not be presented for clinical strains from HUSLAB to protect 
patient identity. 
MDR: strain confirmed to be multidrug resistant.  
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Table S2: Phages used in the phylogenetic tree. 
Phage name  GenBank accession no. 
Pseudomonas phage Kraken KT372692.1 
Pbunalikevirus phiVader KT254130.1 
Pseudomonas phage Poseidon KT372696.1 
Pseudomonas phage Kula KT372693.1 
Pseudomonas phage Nessie KT372695.1 
Pseudomonas aeruginosa isolate ph_PII10A LT594786.1 
Pseudomonas phage SN FM887021.1 
Pseudomonas phage JG024 GU815091.1 
Pseudomonas phage NP3 KU198331.1 
Pseudomonas phage 14-1 FM897211.1 
Pseudomonas phage vB_Pae_PS44 KM434184.1 
Pseudomonas phage vB_PaeM_E215 MF490241.1 
Pseudomonas phage NH-4 JN254800.1 
Pseudomonas phage SL1 MF768470.1 
Pseudomonas phage phiKT28 KP340287.1 
Pseudomonas phage KPP12 DNA  AB560486.1 
Pseudomonas phage vB_PaeM_PAO1_Ab27 LN610579.1 
Pseudomonas phage vB_PaeM_E217 MF490240.1 
Pseudomonas phage vB_PaeM_CEB_DP1 KR869157.1 
Pseudomonas phage BrSP1 MF623055.1 
Pseudomonas phage S12-1 DNA LC102730.1 
Pseudomonas phage LMA2  FM201282.1 
 
 
Table S3: Predicted genes of P. aeruginosa phage fHo-Pae01. Annotations made by Elsi Pulkkinen. Homologs were 
achieved from BLASTp analyzes.  
Locus 
tag 
Position GC 
(%) 
Protein 
length (aa) 
Amino acid sequence identity/similarity to best 
homologs  
(% amino acid identity) 
E-value  
(BLAST) 
Accession no 
FHP001 665 - 1234 59.5 570 hypothetical protein PPSN_gp77 [Pseudomonas 
phage SN]  
hypothetical protein [Pseudomonas phage S12-1]  
7e-138 
 
1e-137 
YP_002418883.1  
 
BAU16489.1 
FHP002c 1401 - 
2015 
56.1 615 hypothetical protein PII10A_02 [Pseudomonas 
aeruginosa]  
hypothetical protein PPSN_gp78 [Pseudomonas 
phage SN]  
1e-142 
 
4e-142 
SBT96684.1  
 
YP_002418884.1 
FHP003c 2207 -
2878 
59.2 672 putative minor head protein [Pseudomonas 
aeruginosa]  
hypothetical protein [Pseudomonas phage KPP12]  
4e-157 
 
1e-143 
SBT96685.1 
 
YP_007238232.1 
FHP004c 2889 -
3200 
55.7 312 hypothetical protein PP141_gp79 [Pseudomonas 
phage 14-1]  
hypothetical protein vBPaeME217_00082 
[Pseudomonas phage vB_PaeM_E217]   
1e-72 
 
7e-72 
YP_002364387.1  
 
ASZ72466.1 
FHP005c 3253-3474 51.4 222 hypothetical protein PP141_gp80 [Pseudomonas 
phage 14-1]  
hypothetical protein I7A_082c [Pseudomonas 
phage NH-4]  
3e-44 
 
6e-44 
YP_002364388.1  
 
YP_007002628.1 
FHP006c 3484 -
3738 
56.9 255 hypothetical protein PP141_gp81 [Pseudomonas 
phage 14-1]  
hypothetical protein [Pseudomonas aeruginosa]  
2e-53 
 
5e-50 
YP_002364389.1  
 
WP_121332560.1 
Supplementary material 
 3 
FHP007c 3792 -
4016 
55.6 225 hypothetical protein LBL3_gp79 [Pseudomonas 
phage LBL3]  
hypothetical protein PPSN_gp83 [Pseudomonas 
phage SN]  
3e-47 
 
2e-46 
YP_002154224.1  
 
YP_002418889.1 
FHP008c 4082 -
4408  
55.7 327 hypothetical protein [Pbunalikevirus phiVader]  
hypothetical protein [Pseudomonas phage E79]  
2e-73 
3e-73 
ALJ99257.1 
AXF41825.1 
FHP009c 4405 -
5052 
59.1 648 hypothetical protein [Pseudomonas phage PA5]  
hypothetical protein PJG24_088 [Pseudomonas 
phage JG024]   
9e-149 
5e-148 
APD20735.1 
YP_006200852.1 
FHP010c 5084 -
5293  
58.1 210 hypothetical protein [Pseudomonas aeruginosa]  
hypothetical protein [Pseudomonas phage 
vB_PaeM_PAO1_Ab27]   
7e-45 
8e-40 
WP_015994944.1 
YP_009124313.1 
FHP011c 5290 -
5505 
51.9 216 hypothetical protein [Pseudomonas phage DL68]  
hypothetical protein PJG24_090 [Pseudomonas 
phage JG024]   
2e-43 
1e-42 
YP_009215142.1 
YP_006200854.1 
FHP012c 5502 -
5702  
54.2 201 hypothetical protein [Pseudomonas phage NP3]  
hypothetical protein PP141_gp87 [Pseudomonas 
phage 14-1]  
5e-41 
8e-41 
AMQ76208.1 
YP_002364395.1 
FHP013c 5699 -
5950  
51.2 252 hypothetical protein LMA2_gp89 [Pseudomonas 
phage LMA2]  
hypothetical protein [Pseudomonas phage NP3] 
1e-53 
 
2e-53
  
YP_002154322.1 
 
AMQ76209.1 
FHP014c 6037 -
6225  
50.3 189 hypothetical protein PP141_gp89 [Pseudomonas 
phage 14-1]  
hypothetical protein PII10A_14 [Pseudomonas 
aeruginosa]  
9e-40 
 
1e-37 
YP_002364397.1 
 
SBT96696.1 
FHP015c 6228 - 
7145 
54.5 918 tail length tape-measure protein [Pseudomonas 
phage E79]  
tail length tape-measure protein [Pseudomonas 
phage NP3]  
0 
 
0 
AXF41778.1 
 
AMQ76211.1 
FHP016c 7192 - 
7494 
53.8 303 hypothetical protein PPSN_gp01 [Pseudomonas 
phage SN]  
hypothetical protein vBPaeMLS1_39 [Pseudomonas 
phage vB_PaeM_LS1]  
5e-64 
 
4e-60 
YP_002418807.1 
 
AVJ48808.1 
FHP017c 7822 - 
7968 
53.1 147 hypothetical protein PPSN_gp03 [Pseudomonas 
phage SN]  
hypothetical protein SAMN05216409_118116 
[Pseudomonas lutea] 
6e-23 
 
6e-13 
YP_002418809.1 
 
SER37912.1 
FHP018 8144 - 
9526 
53.1 1383 terminase large subunit [Pseudomonas phage 
vB_Pae436M-8]  
putative terminase large subunit [Pseudomonas 
phage LBL3]  
0 
 
0 
ANT44190.1 
 
YP_002154147.1 
FHP019c 9563 - 
9946 
59.4 384 hypothetical protein PP141_gp04 [Pseudomonas 
phage 14-1]  
hypothetical protein [Pseudomonas phage NP3]  
5e-85 
 
1e-84 
YP_002364312.1 
 
AMQ76120.1 
FHP020c 9943 - 
10161 
58.0 219 hypothetical protein PPSN_gp06 [Pseudomonas 
phage SN]  
hypothetical protein BrSP1_22 [Pseudomonas 
phage BrSP1]  
1e-44 
 
3e-44 
YP_002418812.1 
 
ATI16273.1 
FHP021c 10161 - 
10511 
61.8 351 hypothetical protein PPSN_gp07 [Pseudomonas 
phage SN]  
hypothetical protein SL1_06 [Pseudomonas phage 
SL1]  
4e-78 
 
1e-75 
YP_002418813.1 
 
AUS03281.1 
FHP022c 10555 - 
10953 
59.4 399 hypothetical protein [Pseudomonas phage DL68]  
hypothetical protein LBL3_gp06 [Pseudomonas 
phage LBL3]  
8e-86 
1e-84 
YP_009215129.1 
YP_002154151.1 
FHP023c 10956 - 
11735 
55.6 780 hypothetical protein PP141_gp08 [Pseudomonas 
phage 14-1]  
hypothetical protein vB_Pae_PS44_00009 
[Pseudomonas phage vB_Pae_PS44]  
0 
 
0 
YP_002364316.1 
 
YP_009211333.1 
FHP024c 11823 - 
12254 
61.3 432 hypothetical protein BrSP1_26 [Pseudomonas 
phage BrSP1]  
hypothetical protein [Pseudomonas aeruginosa]  
3e-82 
 
6e-80 
ATI16277.1 
 
WP_121332544.1 
FHP025c 12271 - 
12858 
57.7 588 hypothetical protein [Pseudomonas phage NP3]  
hypothetical protein PP141_gp10 [Pseudomonas 
phage 14-1]  
2e-143 
1e-142 
AMQ76126.1 
YP_002364318.1 
FHP026c 12868 - 
12963 
52.1 96 hypothetical protein vBPaeME215_00084 
[Pseudomonas phage vB_PaeM_E215]  
hypothetical protein vB_Pae_PS44_00012 
[Pseudomonas phage vB_Pae_PS44]  
4e-11 
 
1e-10 
ASZ72562.1 
 
YP_009211336.1 
FHP027c 12960 - 
13892 
56.8 933 hypothetical protein vBPaeME215_00085 
[Pseudomonas phage vB_PaeM_E215]  
hypothetical protein PP141_gp12 [Pseudomonas 
phage 14-1]  
0 
 
0 
ASZ72563.1 
 
YP_002364320.1 
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FHP028c 13996 - 
14496 
57.1 501 hypothetical protein vBPaeME215_00086 
[Pseudomonas phage vB_PaeM_E215]  
hypothetical protein PPSN_gp14 [Pseudomonas 
phage SN]  
4e-120 
 
1e-119 
ASZ72564.1 
 
YP_002418820.1 
FHP029 14519 - 
14686 
49.4 168 ERROR: "No significant similarity found"   
FHP030c 14987 - 
15298 
52.6 312 hypothetical protein PII10A_31 [Pseudomonas 
aeruginosa]  
hypothetical protein [Pseudomonas phage 
vB_PaeM_PAO1_Ab27]  
3e-68 
 
3e-67 
SBT96713.1 
 
YP_009124336.1 
FHP031c 15304 - 
15516 
58.2 213 hypothetical protein [Burkholderia vietnamiensis]  
hypothetical protein vB_Pae_PS44_00018 
[Pseudomonas phage vB_Pae_PS44]  
4e-41 
2e-40 
WP_016057510.1 
YP_009211342.1 
FHP032c 15504 - 
15827 
56.5 324 hypothetical protein LMA2_gp15 [Pseudomonas 
phage LMA2]  
hypothetical protein vB_Pae_PS44_00019 
[Pseudomonas phage vB_Pae_PS44]  
3e-75 
 
2e-73 
YP_002154249.1  
 
YP_009211343.1 
FHP033c 15859 - 
16260 
53.0 402 hypothetical protein LMA2_gp16 [Pseudomonas 
phage LMA2]  
hypothetical protein [Pseudomonas phage 
vB_PaeM_PAO1_Ab27]   
2e-92 
 
9e-92 
YP_002154250.1  
 
YP_009124339.1  
FHP034 16441 - 
18738 
56.9 2298 putative portal protein [Pseudomonas aeruginosa]  
putative minor head protein [Pseudomonas phage 
PB1]  
0 
 
0 
SBT96717.1  
 
YP_002455948.1  
FHP035 18738 - 
19574 
53.6 837 putative minor head protein [Pseudomonas phage 
KPP12]  
putative head protein [Pseudomonas phage PB1] 
0 
 
0 
YP_007238173.1 
 
YP_002455949.1 
FHP036 19593 - 
19799 
55.6 207 hypothetical protein PPSN_gp21 [Pseudomonas 
phage SN]  
hypothetical protein LBL3_gp17 [Pseudomonas 
phage LBL3]   
2e-41 
 
6e-40 
YP_002418827.1  
 
YP_002154162.1 
FHP037 19796 - 
19936 
53.2 141 hypothetical protein PPSN_gp22 [Pseudomonas 
phage SN]  
hypothetical protein PJG24_021 [Pseudomonas 
phage JG024]  
4e-23 
 
4e-22 
YP_002418828.1  
 
YP_006200786.1 
FHP038 19936 - 
20061 
42.9 126 No significant similarity found.   
FHP039 20489 - 
21871 
58.2 1383 hypothetical protein [Pseudomonas phage DL68]  
hypothetical protein PP141_gp22 [Pseudomonas 
phage 14-1]   
0 
0 
YP_009215206.1 
YP_002364330.1 
FHP040 21875 - 
22510 
62.6 636 hypothetical protein PP141_gp23 [Pseudomonas 
phage 14-1]   
structural protein [Pseudomonas phage SN]  
5e-148 
 
2e-147 
YP_002364331.1  
 
YP_002418830.1 
FHP041 22520 - 
23668 
61.0 1149 hypothetical protein PP141_gp24 [Pseudomonas 
phage 14-1]   
putative major structural protein [Pseudomonas 
phage LMA2]   
0 
 
0 
YP_002364332.1  
 
YP_002154257.1 
FHP042 23770 - 
24207 
55.3 438 hypothetical protein [Pseudomonas aeruginosa]  
hypothetical protein [Pseudomonas phage KPP12]  
6e-104 
2e-103 
WP_121332534.1 
YP_007238179.1 
FHP043 24222 - 
24689 
59.4 468 DUF4054 domain-containing protein [Pseudomonas 
aeruginosa]  
putative structural protein [Pseudomonas phage 
LMA2]   
5e-110 
 
2e-108 
WP_016066139.1  
 
YP_002154259.1  
FHP044 24686 - 
25084 
52.1 399 putative structural protein [Pseudomonas phage 
KPP12]  
structural protein [Pseudomonas phage phiKTN6]  
4e-92 
 
1e-91 
YP_007238181.1  
 
AKJ71558.1 
FHP045 25092 - 
25643 
48.2 552 hypothetical protein vBPaeME215_00007 
[Pseudomonas phage vB_PaeM_E215]  
hypothetical protein [Pseudomonas phage 
vB_PaeM_PAO1_Ab27]   
1e-133 
 
2e-133 
ASZ72485.1  
 
YP_009124349.1 
FHP046 25640 - 
26221 
54.8 582 hypothetical protein [Pseudomonas aeruginosa]  
hypothetical protein [Pseudomonas phage KPP12]  
3e-137 
1e-136 
WP_015981230.1 
YP_007238183.1 
FHP047 26237 - 
27751 
59.8 1515 hypothetical protein vB_Pae436M-8_30 
[Pseudomonas phage vB_Pae436M-8]  
putative structural protein [Pseudomonas phage 
LMA2]   
0 
 
0 
ANT44216.1  
 
YP_002154263.1 
FHP048 27810 - 
28262 
59.2 453 hypothetical protein [Pseudomonas aeruginosa]  
structural protein [Pseudomonas phage phiKT28]  
2e-103 
2e-102 
WP_015992745.1 
AKJ71471.1 
FHP049 28262 - 
28585 
54.3 324 hypothetical protein [Pseudomonas aeruginosa]  
putative structural protein [Pseudomonas phage 
JG024]   
2e-75 
6e-75 
WP_015992746.1 
YP_006200797.1 
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FHP050 28582 - 
28932 
52.4 351 hypothetical protein [Pseudomonas aeruginosa]  
structural protein [Pseudomonas phage SL1]  
3e-78 
1e-77 
WP_015992747.1 
AUS03345.1 
FHP051 28934 - 
29365 
63.9 432 hypothetical protein LMA2_gp33 [Pseudomonas 
phage LMA2]  
hypothetical protein vBPaeMDP1_0034 
[Pseudomonas phage vB_PaeM_CEB_DP1]  
6e-94 
 
4e-93 
YP_002154267.1  
 
AKP24421.1 
FHP052 29375 - 
29878 
51.6 504 hypothetical protein [Pseudomonas aeruginosa]  
structural protein [Pseudomonas phage SN]  
3e-114 
6e-114 
WP_015992749.1 
YP_002418842.1 
FHP053 29878 - 
30417 
51.1 540 putative structural protein [Pseudomonas phage 
LMA2]  
putative structural protein [Pseudomonas phage 
LBL3]   
6e-128 
 
2e-127 
YP_002154269.1  
 
YP_002154178.1 
FHP054 30426 - 
31019 
47.3 594 putative structural protein [Pseudomonas phage 
KPP12] 
hypothetical protein vBPaeME217_00038 
[Pseudomonas phage vB_PaeM_E217]   
4e-138 
 
2e-137 
YP_007238190.1  
 
ASZ72422.1 
FHP055 31029 - 
31457 
56.6 429 hypothetical protein [Pseudomonas aeruginosa]  
hypothetical protein LMA2_gp37 [Pseudomonas 
phage LMA2]   
5e-101 
2e-100 
WP_121332529.1 
YP_002154271.1 
FHP056 31461 - 
34037 
58.1 2577 putative lytic tail protein [Pseudomonas phage 
LMA2]  
internal (core) protein [Pseudomonas phage NP3]  
0 
 
0 
YP_002154272.1  
 
AMQ76156.1 
FHP057 34037 - 
34900 
51.9 864 putative structural protein [Pseudomonas phage 
LMA2]  
putative structural protein [Pseudomonas phage 
vB_PaeM_CEB_DP1]   
0 
 
0 
YP_002154273.1  
 
AKP24427.1 
FHP058 34900 - 
35433 
48.1 534 hypothetical protein PP141_gp41 [Pseudomonas 
phage 14-1]  
hypothetical protein [Pseudomonas phage DL68]  
2e-127 
 
6e-127 
YP_002364349.1  
 
YP_009215187.1 
FHP059 35828 - 
36154 
53.2 327 putative baseplate protein [Pseudomonas phage 
JG024]  
baseplate protein [Pseudomonas phage phiKTN6]  
1e-71 
 
1e-71 
YP_006200807.1 
 
AKJ71573.1 
FHP060 36211 - 
37464 
57.7 1254 putative structural protein [Pseudomonas phage 
LMA2] 
putative baseplate protein [Pseudomonas phage 
SN]  
0 
 
0 
YP_002154276.1  
 
YP_002418850.1 
FHP061 37461 - 
38975 
56.0 1515 hypothetical protein PP141_gp44 [Pseudomonas 
phage 14-1]  
structural protein [Pseudomonas phage 
vB_Pae436M-8]   
0 
 
0 
YP_002364352.1  
 
ANT44230.1 
FHP062 38980 - 
41874 
57.1 2895 hypothetical protein vBPaeME215_00024 
[Pseudomonas phage vB_PaeM_E215]  
putative tail fiber protein [Pseudomonas 
aeruginosa]  
0 
 
0 
ASZ72502.1  
 
SBT96745.1 
FHP063 41876 - 
42304 
58.5 429 tail fibers component [Pseudomonas phage 
phiKTN6]  
hypothetical protein [Pseudomonas phage 
vB_PaeM_PAO1_Ab27]  
3e-99 
 
3e-99 
AKJ71577.1  
 
YP_009124367.1 
FHP064 42304 - 
42966 
60 663 putative lytic enzyme [Pseudomonas phage 
vB_PaeM_PAO1_Ab27]  
endolysin [Pseudomonas phage PB1]   
3e-162 
 
9e-161 
YP_009124368.1  
 
YP_002455978.1 
FHP065c 42990 - 
43241 
51.2 252 hypothetical protein PP141_gp48 [Pseudomonas 
phage 14-1]  
hypothetical protein LMA2_gp47 [Pseudomonas 
phage LMA2]   
2e-50 
 
3e-50 
YP_002364356.1  
 
YP_002154281.1 
FHP066c 43521 - 
44432 
57.2 912 putative DNA ligase [Pseudomonas aeruginosa]  
hypothetical protein PP141_gp49 [Pseudomonas 
phage 14-1]   
0 
0 
SBT96752.1 
YP_002364357.1 
FHP067c 44487 - 
45041 
53.7 555 hypothetical protein I7A_051c [Pseudomonas 
phage NH-4]  
hypothetical protein [Pseudomonas phage KPP22]  
2e-133 
 
5e-133 
YP_007002597.1  
 
BAU20664.1 
FHP068c 45038 - 
45646 
60.6 609 hypothetical protein vBPaeME215_00030 
[Pseudomonas phage vB_PaeM_E215]  
hypothetical protein ORF050 [Pseudomonas phage 
F8]   
9e-139 
 
 
1e-136 
ASZ72508.1  
 
 
YP_001294467.1 
FHP069c 45700 - 
46599 
60.1 900 hypothetical protein PP141_gp52 [Pseudomonas 
phage 14-1]  
hypothetical protein [Pseudomonas phage DL68] 
  
0 
 
0 
YP_002364360.1  
 
YP_009215176.1 
FHP070c 46688 - 
47308 
53.9 621 hypothetical protein LMA2_gp52 [Pseudomonas 
phage LMA2]  
hypothetical protein I7A_054c [Pseudomonas 
phage NH-4]   
3e-145 
 
3e-145 
YP_002154286.1  
 
YP_007002600.1 
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FHP071c 47403 - 
48962 
54.6 1560 DNA helicase [Pseudomonas phage DL68]  
hypothetical protein PP141_gp54 [Pseudomonas 
phage 14-1]   
0 
0 
YP_009215174.1 
YP_002364362.1 
FHP072c 48959 - 
49369 
55.7 411 hypothetical protein [Pseudomonas phage KPP12]  
putative DNA helicase [Pseudomonas phage NH-4]  
2e-94 
 
3e-94 
YP_007238208.1  
 
YP_007002602.1 
FHP073c 49362 - 
52469 
55.2 3108 DNA polymerase III alpha subunit [Pseudomonas 
phage vB_PaeM_LS1] 
putative DNA polymerase [Pseudomonas phage 
KPP12]   
0 
 
0 
AVJ48844.1  
 
YP_007238209.1 
FHP074c 52469 - 
53023 
53.0 555 putative DNA polymerase III epsilon subunit 
[Pseudomonas phage NH-4]  
putative DNA polymerase III epsilon subunit 
[Pseudomonas phage LMA2]   
2e-135 
 
3e-135 
YP_007002604.1  
 
YP_002154290.1 
FHP075c 53099 - 
54115 
58.4 1017 hypothetical protein PP141_gp58 [Pseudomonas 
phage 14-1]  
putative 3'-phosphatase 5'-polynucleotide kinase 
[Pseudomonas aeruginosa]  
0 
 
0 
YP_002364366.1  
 
SBT96767.1 
FHP076c 54118 - 
54309 
47.4 192 hypothetical protein phiKT28_061 [Pseudomonas 
phage phiKT28]  
hypothetical protein PJG24_060 [Pseudomonas 
phage JG024]   
1e-35 
 
3e-35 
AKJ71499.1  
 
YP_006200824.1 
FHP077c 54311 - 
55228 
58.0 918 putative thymidylate synthase [Pseudomonas 
phage KPP12]  
putative thymidylate synthase [Pseudomonas 
phage JG024]   
0 
 
0 
YP_007238213.1  
 
YP_006200825.1 
FHP078c 55228 - 
55434 
51.7 207 hypothetical protein [Pseudomonas phage KPP12]  
hypothetical protein [Pseudomonas phage PA5]  
7e-40 
1e-39 
YP_007238214.1  
APD20762.1 
FHP079c 55442 - 
55672 
56.7 231 hypothetical protein PPSN_gp63 [Pseudomonas 
phage SN]  
hypothetical protein PP141_gp62 [Pseudomonas 
phage 14-1]  
5e-49 
 
1e-48 
YP_002418869.1  
 
YP_002364370.1 
FHP080c 55705 - 
55923 
53.9 219 hypothetical protein LMA2_gp62 [Pseudomonas 
phage LMA2]  
tail assembly protein [Pseudomonas phage 
phiKTN6]   
2e-46 
 
9e-46 
YP_002154296.1  
 
AKJ71594.1 
FHP081c 55907 - 
56125 
58.0 219 hypothetical protein phiKTN6_063 [Pseudomonas 
phage phiKTN6]  
hypothetical protein I7A_065c [Pseudomonas 
phage NH-4]   
1e-43 
 
1e-43 
AKJ71595.1  
 
YP_007002611.1 
FHP082c 56125 - 
56355 
58.9 231 hypothetical protein PP141_gp65 [Pseudomonas 
phage 14-1]  
hypothetical protein LBL3_gp62 [Pseudomonas 
phage LBL3]   
6e-50 
 
1e-49 
YP_002364373.1  
 
YP_002154207.1 
FHP083c 56443 - 
57444 
55.3 1002 hypothetical protein PP141_gp66 [Pseudomonas 
phage 14-1]  
hypothetical protein ORF065 [Pseudomonas phage 
F8]   
0 
 
0 
YP_002364374.1  
 
YP_001294482.1 
FHP084c 57552 - 
58370 
62.0 819 hypothetical protein [Pseudomonas phage NP3]  
hypothetical protein PP141_gp67 [Pseudomonas 
phage 14-1]   
4e-177 
2e-102 
AMQ76185.1 
YP_002364375.1 
FHP085c 58532 - 
59719 
55.1 1188 putative ATP-dependent exonuclease V 
[Pseudomonas phage SN]  
ATP-dependent exonuclease [Pseudomonas phage 
PB1]   
0 
 
0 
YP_002418875.1  
 
YP_002456000.1 
FHP086c 59706 - 
60128 
56.7 423 hypothetical protein PP141_gp69 [Pseudomonas 
phage 14-1]  
hypothetical protein ORF068 [Pseudomonas phage 
F8]   
4e-98 
 
2e-97 
YP_002364377.1  
 
YP_001294485.1 
FHP087 60297 - 
61118 
58.6 822 hypothetical protein PJG24_071 [Pseudomonas 
phage JG024] 
hypothetical protein PP141_gp70 [Pseudomonas 
phage 14-1] 
0 
 
0 
YP_006200835.1  
 
YP_002364378.1 
FHP088 61129 - 
62433 
58.5 1305 hypothetical protein PP141_gp71 [Pseudomonas 
phage 14-1] 
hypothetical protein LBL3_gp68 [Pseudomonas 
phage LBL3] 
0 
 
0 
YP_002364379.1  
 
YP_002154213.1 
FHP089 62457 - 
62906 
58.0 450 hypothetical protein PP141_gp72 [Pseudomonas 
phage 14-1] 
hypothetical protein [Pseudomonas phage NP3]  
4e-106 
 
6e-106 
YP_002364380.1  
 
AMQ76190.1 
FHP090 62903 - 
63979 
57.5 1077 hypothetical protein PP141_gp73 [Pseudomonas 
phage 14-1] 
hypothetical protein vBPaeMLS1_59 [Pseudomonas 
phage vB_PaeM_LS1]  
0 
 
0 
YP_002364381.1  
 
AVJ48828.1 
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FHP091 63985 - 
64134 
50 150 hypothetical protein ORF073 [Pseudomonas phage 
F8]  
hypothetical protein phiKTN6_073 [Pseudomonas 
phage phiKTN6]  
3e-10 
 
3e-10 
YP_001294490.1  
 
AKJ71605.1 
FHP092 64317 - 
66056 
54.0 1740 putative DNA primase [Pseudomonas phage 
vB_PaeM_CEB_DP1]  
DNA primase [Pseudomonas phage vB_Pae436M-8]  
0 
 
0 
AKP24459.1  
 
ANT44262.1 
 
Table S4: Predicted genes of P. aeruginosa phage PA1P1. Homologs were achieved from BLASTp analyzes. 
Locus tag Position GC 
(%) 
Protein 
lenght (aa) 
Amino acid sequence identity/similarity to best 
homologs (% amino acid identity) 
E-value (BLAST) Accession no. 
PA1P1_001 604 - 1185 58.2 193 hypothetical protein [Pseudomonas phage 
vB_PaeM_PAO1_Ab27] 
hypothetical protein LMA2_gp76 [Pseudomonas 
phage LMA2] 
4E-137 
 
3E-136 
YP_009124304.1 
 
YP_002154309.1 
PA1P1_002c 1953 - 
1342 
55.1 203 hypothetical protein PP141_gp77 [Pseudomonas 
phage 14-1] 
hypothetical protein SL1_26 [Pseudomonas phage 
SL1] 
5E-144 
 
3E-143 
YP_002364385.1 
 
AUS03301.1 
PA1P1_003c 2829 - 
2143 
60.0 228 hypothetical protein PP141_gp78 [Pseudomonas 
phage 14-1] 
hypothetical protein vBPaeME215_00057 
[Pseudomonas phage vB_PaeM_E215] 
3E-157 
 
1E-156 
YP_002364386.1 
 
ASZ72535.1 
PA1P1_004c 3151 - 
2840 
55.8 103 hypothetical protein vBPaeMDP1_0076 
[Pseudomonas phage vB_PaeM_CEB_DP1] 
hypothetical protein BrSP1_5 [Pseudomonas phage 
BrSP1] 
1E-71 
 
4E-71 
AKP24463.1 
 
ATI16257.1 
PA1P1_005c 3425 - 
3204 
52.7 73 hypothetical protein PP141_gp80 [Pseudomonas 
phage 14-1] 
hypothetical protein I7A_082c [Pseudomonas phage 
NH-4] 
3E-44 
 
5E-44 
YP_002364388.1 
 
YP_007002628.1 
PA1P1_006c 3689 - 
3435 
56.9 84 hypothetical protein PP141_gp81 [Pseudomonas 
phage 14-1] 
hypothetical protein [Pseudomonas phage KPP22] 
2E-53 
 
5E-49 
YP_002364389.1 
 
BAU20633.1 
PA1P1_007c 3967 - 
3743 
55.6 74 hypothetical protein LBL3_gp79 [Pseudomonas phage 
LBL3] 
hypothetical protein PPSN_gp83 [Pseudomonas phage 
SN] 
3E-47 
 
2E-46 
YP_002154224.1 
 
YP_002418889.1 
PA1P1_008c 4359 - 
4033 
55.4 108 hypothetical protein [Pbunalikevirus phiVader] 
hypothetical protein [Pseudomonas phage E79] 
2E-73 
2E-73 
ALJ99257.1 
AXF41825.1 
PA1P1_009c 5003 - 
4356 
59.7 215 hypothetical protein LBL3_gp81 [Pseudomonas phage 
LBL3] 
hypothetical protein vB_Pae_PS44_00086 
[Pseudomonas phage vB_Pae_PS44] 
1E-154 
 
2E-152 
YP_002154226.1 
 
YP_009211410.1 
PA1P1_010c 5247 - 
5035 
56.3 70 hypothetical protein phiKTN6_084 [Pseudomonas 
phage phiKTN6] 
hypothetical protein [Pseudomonas phage KPP12] 
2E-45 
 
4E-44 
AKJ71616.1 
 
YP_007238238.1 
PA1P1_011c 5432 - 
5244 
49.2 62 hypothetical protein LBL3_gp83 [Pseudomonas phage 
LBL3] 
hypothetical protein LMA2_gp86 [Pseudomonas 
phage LMA2] 
4E-38 
 
4E-35 
YP_002154228.1 
 
YP_002154319.1 
PA1P1_012c 5644 - 
5429 
53.7 71 hypothetical protein LBL3_gp84 [Pseudomonas phage 
LBL3] 
hypothetical protein PB1_gp89 [Pseudomonas phage 
PB1] 
1E-43 
 
2E-43 
YP_002154229.1 
 
YP_002456018.1 
PA1P1_013c 5841 - 
5641 
54.2 66 hypothetical protein PPSN_gp89 [Pseudomonas phage 
SN] 
hypothetical protein [Pseudomonas phage NP3] 
4E-41 
 
3E-40 
YP_002418895.1 
 
AMQ76208.1 
PA1P1_014c 6089 - 
5838 
52.0 83 hypothetical protein PJG24_092 [Pseudomonas phage 
JG024] 
hypothetical protein PII10A_13 [Pseudomonas 
aeruginosa] 
2E-53 
1E-52 
YP_006200856.1 
SBT96695.1 
PA1P1_015c 6364 - 
6176 
49.7 62 hypothetical protein PP141_gp89 [Pseudomonas 
phage 14-1] 
hypothetical protein PII10A_14 [Pseudomonas 
aeruginosa] 
3E-39 
 
5E-37 
YP_002364397.1 
 
SBT96696.1 
PA1P1_016c 7284 - 
6367 
54.6 305 tail length tape-measure protein [Pseudomonas phage 
NP3] 
tail length tape-measure protein [Pseudomonas phage 
E79] 
0 
 
0 
AMQ76211.1 
 
AXF41778.1 
PA1P1_017c 7633 -
7331 
53.1 100 hypothetical protein PPSN_gp01 [Pseudomonas phage 
SN] 
1E-63 
 
8E-61 
YP_002418807.1 
 
AVJ48808.1 
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hypothetical protein vBPaeMLS1_39 [Pseudomonas 
phage vB_PaeM_LS1] 
PA1P1_018c 7862 - 
7689 
54.0 57 hypothetical protein PPSN_gp02 [Pseudomonas phage 
SN] 
hypothetical protein PII10A_17 [Pseudomonas 
aeruginosa] 
9E-35 
 
2E-34 
YP_002418808.1 
 
SBT96699.1 
PA1P1_019c 8059 - 
7913 
53.1 48 hypothetical protein PPSN_gp03 [Pseudomonas phage 
SN] 
hypothetical protein SAMN05216409_118116 
[Pseudomonas lutea] 
5E-23 
 
6E-13 
YP_002418809.1 
 
SER37912.1 
PA1P1_020 8236 - 
9618 
52.4 460 putative terminase, large subunit [Pseudomonas 
aeruginosa] 
terminase large subunit [Pseudomonas phage E79] 
0 
 
0 
SBT96701.1 
 
AXF41768.1 
PA1P1_021c 10038 - 
9655 
59.1 127 hypothetical protein PP141_gp04 [Pseudomonas 
phage 14-1] 
hypothetical protein [Pseudomonas phage NP3] 
3E-86 
 
7E-86 
YP_002364312.1 
 
AMQ76120.1 
PA1P1_022c 10253 - 
10035 
54.8 72 hypothetical protein [Pseudomonas aeruginosa] 
hypothetical protein [Pseudomonas phage NP3] 
4E-46 
3E-45 
WP_015994883.1 
AMQ76121.1 
PA1P1_023c 10603 - 
10253 
61.3 116 hypothetical protein LBL3_gp05 [Pseudomonas phage 
LBL3] 
hypothetical protein SL1_06 [Pseudomonas phage 
SL1] 
4E-78 
 
8E-76 
YP_002154150.1 
 
AUS03281.1 
PA1P1_024c 11050 - 
10649 
59.5 133 hypothetical protein PP141_gp07 [Pseudomonas 
phage 14-1] 
hypothetical protein PJG24_008 [Pseudomonas phage 
JG024] 
2E-89 
 
1E-88 
YP_002364315.1 
 
YP_006200773.1 
PA1P1_025c 11832 - 
11053 
56.9 259 hypothetical protein PP141_gp08 [Pseudomonas 
phage 14-1] 
hypothetical protein [Pseudomonas phage DL68] 
0 
 
0 
YP_002364316.1 
 
YP_009215128.1 
PA1P1_026c 12356 - 
11919 
61.4 145 hypothetical protein PJG24_010 [Pseudomonas phage 
JG024] 
hypothetical protein [Pseudomonas phage DL68] 
4E-98 
 
7E-98 
YP_006200775.1 
 
YP_009215127.1 
PA1P1_027c 12960 - 
12373 
58.3 195 hypothetical protein [Pseudomonas phage NP3] 
hypothetical protein PP141_gp10 [Pseudomonas 
phage 14-1] 
4E-144 
2E-143 
AMQ76126.1 
YP_002364318.1 
PA1P1_028c 13065 - 
12970 
49.0 31 hypothetical protein [Pseudomonas phage NP3] 
hypothetical protein PP141_gp10 [Pseudomonas 
phage 14-1] 
9E-138 
5E-137 
AMQ76126.1 
YP_002364318.1 
PA1P1_029c 13994 - 
13062 
57.2 310 hypothetical protein vB_Pae_PS44_00013 
[Pseudomonas phage vB_Pae_PS44] 
hypothetical protein PPSN_gp13 [Pseudomonas phage 
SN] 
0 
 
0 
YP_009211337.1 
 
YP_002418819.1 
PA1P1_030c 14597 - 
14097 
55.7 166 hypothetical protein PP141_gp13 [Pseudomonas 
phage 14-1] 
hypothetical protein PJG24_013 [Pseudomonas phage 
JG024] 
4E-120 
 
2E-119 
YP_002364321.1 
 
YP_006200778.1 
PA1P1_031c 14964 - 
14617 
53.4 115 hypothetical protein PP141_gp14 [Pseudomonas 
phage 14-1] 
hypothetical protein [Pseudomonas phage DL68] 
5E-77 
 
7E-77 
YP_002364322.1 
 
YP_009215123.1 
PA1P1_032c 15524 - 
15213 
51.3 103 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein PJG24_015 [Pseudomonas phage 
JG024] 
2E-68 
2E-67 
YP_009215122.1 
YP_006200780.1 
PA1P1_033c 15733 - 
15530 
58.3 67 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein phiKT28_017 [Pseudomonas 
phage phiKT28] 
3E-41 
1E-40 
YP_009215121.1 
AKJ71455.1 
PA1P1_034c 16053 - 
15730 
55.6 107 hypothetical protein PP141_gp16 [Pseudomonas 
phage 14-1] 
hypothetical protein PJG24_016 [Pseudomonas phage 
JG024] 
1E-74 
 
6E-73 
YP_002364324.1 
 
YP_006200781.1 
PA1P1_035c 16485 - 
16084 
53.7 133 hypothetical protein PP141_gp17 [Pseudomonas 
phage 14-1] 
hypothetical protein phiKT28_019 [Pseudomonas 
phage phiKT28] 
2E-92 
 
9E-92 
YP_002364325.1 
 
AKJ71457.1 
PA1P1_036 16665 - 
18962 
56.9 729 hypothetical protein [Pseudomonas phage DL68] 
minor head-like protein [Pseudomonas phage 14-1] 
0 
0 
YP_009215210.1 
YP_002364326.1 
PA1P1_037 18962 - 
19798 
53.4 278 putative minor head protein [Pseudomonas phage SN] 
putative minor head protein [Pseudomonas phage 
SL1] 
0 
 
0 
YP_002418826.1 
 
AUS03359.1 
PA1P1_038 19817 - 
20023 
55.6 68 hypothetical protein PPSN_gp21 [Pseudomonas phage 
SN] 
hypothetical protein LBL3_gp17 [Pseudomonas phage 
LBL3] 
2E-41 
 
6E-40 
YP_002418827.1 
 
YP_002154162.1 
PA1P1_039 20020 - 
20160 
53.2 46 hypothetical protein PPSN_gp22 [Pseudomonas phage 
SN] 
4E-23 
 
3E-22 
YP_002418828.1 
 
YP_006200786.1 
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hypothetical protein PJG24_021 [Pseudomonas phage 
JG024] 
PA1P1_040 20714 - 
22108 
58.3 464 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein PP141_gp22 [Pseudomonas 
phage 14-1] 
0 
0 
YP_009215206.1 
YP_002364330.1 
PA1P1_041 22112 - 
22747 
62.6 211 hypothetical protein PP141_gp23 [Pseudomonas 
phage 14-1] 
structural protein [Pseudomonas phage SN] 
5E-148 
 
1E-147 
YP_002364331.1 
 
YP_002418830.1 
PA1P1_042 22757 - 
23905 
61.0 382 putative major structural protein [Pseudomonas 
phage vB_PaeM_CEB_DP1] 
hypothetical protein PP141_gp24 [Pseudomonas 
phage 14-1] 
0 
 
0 
AKP24411.1 
 
YP_002364332.1 
PA1P1_043 24007- 
24444 
55.0 145 hypothetical protein vBPaeMDP1_0025 
[Pseudomonas phage vB_PaeM_CEB_DP1] 
hypothetical protein [Pseudomonas phage KPP12] 
6E-104 
 
2E-103 
AKP24412.1 
 
YP_007238179.1 
PA1P1_044 24459 - 
24926 
59.2 155 putative structural protein [Pseudomonas phage 
KPP12] 
structural protein [Pseudomonas phage phiKTN6] 
4E-110 
 
1E-109 
YP_007238180.1 
 
AKJ71557.1 
PA1P1_045 24923 - 
25321 
52.1 132 putative structural protein [Pseudomonas phage 
KPP12] 
structural protein [Pseudomonas phage phiKTN6] 
2E-91 
 
6E-91 
YP_007238181.1 
 
AKJ71558.1 
PA1P1_046 25329 - 
25880 
48.4 183 hypothetical protein [Pseudomonas phage KPP12] 
hypothetical protein vB_Pae_PS44_00031 
[Pseudomonas phage vB_Pae_PS44] 
3E-133 
5E-133 
YP_007238182.1 
YP_009211355.1 
PA1P1_047 25877 - 
26458 
54.8 193 hypothetical protein ORF028 [Pseudomonas phage F8] 
hypothetical protein [Pseudomonas phage KPP12] 
3E-137 
1E-136 
YP_001294445.1 
YP_007238183.1 
PA1P1_048 26474 - 
27988 
59.1 504 hypothetical protein I7A_031 [Pseudomonas phage 
NH-4] 
hypothetical protein vBPaeMDP1_0030 
[Pseudomonas phage vB_PaeM_CEB_DP1] 
0 
 
0 
YP_007002577.1 
 
AKP24417.1 
PA1P1_049 28047 - 
28499 
59.6 150 putative structural protein [Pseudomonas phage 
LMA2] 
structural protein [Pseudomonas phage phiKT28] 
2E-103 
 
2E-102 
YP_002154264.1 
 
AKJ71471.1 
PA1P1_050 28499 - 
28822 
54.6 107 putative structural protein [Pseudomonas phage 
LMA2] 
putative structural protein [Pseudomonas phage 
JG024] 
2E-75 
 
5E-75 
YP_002154265.1 
 
YP_006200797.1 
PA1P1_051 28819 - 
29169 
53.0 116 putative structural protein [Pseudomonas phage 
LMA2] 
structural protein [Pseudomonas phage SL1] 
3E-78 
 
1E-77 
YP_002154266.1 
 
AUS03345.1 
PA1P1_052 29171 - 
29602 
64.1 143 hypothetical protein PPSN_gp35 [Pseudomonas phage 
SN] 
hypothetical protein PII10A_51 [Pseudomonas 
aeruginosa] 
8E-93 
 
2E-92 
YP_002418841.1 
 
SBT96733.1 
PA1P1_053 29612 - 
30115 
52.2 167 structural protein [Pseudomonas phage SN] 
putative structural protein [Pseudomonas phage 
LMA2] 
3E-115 
1E-114 
YP_002418842.1 
YP_002154268.1 
PA1P1_054 30115 - 
30654 
51.1 179 putative structural protein [Pseudomonas phage 
LMA2] 
putative structural protein [Pseudomonas phage 
LBL3] 
5E-128 
 
2E-127 
YP_002154269.1 
 
YP_002154178.1 
PA1P1_055 30663 - 
31256 
46.8 197 putative structural protein [Pseudomonas phage 
KPP12] 
hypothetical protein vBPaeME217_00038 
[Pseudomonas phage vB_PaeM_E217] 
3E-140 
 
2E-139 
YP_007238190.1 
 
ASZ72422.1 
PA1P1_056 31266 - 
31694 
57.1 142 hypothetical protein LBL3_gp35 [Pseudomonas 
phage LBL3] 
hypothetical protein phiKTN6_037 [Pseudomonas 
phage phiKTN6] 
4E-101 
 
2E-100 
YP_002154180.1 
 
AKJ71569.1 
PA1P1_057 31698 - 
34274 
58.2 858 putative lytic tail protein [Pseudomonas phage 
LMA2] 
internal (core) protein [Pseudomonas phage NP3] 
0 
 
0 
YP_002154272.1 
 
AMQ76156.1 
PA1P1_058 34274 - 
35137 
52.1 287 putative structural protein [Pseudomonas phage 
LMA2] 
putative structural protein [Pseudomonas phage 
vB_PaeM_CEB_DP1] 
0 
 
0 
YP_002154273.1 
 
AKP24427.1 
PA1P1_059 35137 - 
35670 
48.3 177 hypothetical protein PP141_gp41 [Pseudomonas 
phage 14-1] 
hypothetical protein [Pseudomonas phage DL68] 
2E-127 
 
5E-127 
YP_002364349.1 
 
YP_009215187.1 
PA1P1_060 35726 - 
36391 
53.0 221 hypothetical protein LMA2_gp41 [Pseudomonas 
phage LMA2] 
putative baseplate [Pseudomonas phage KPP12] 
2E-160 
 
4E-160 
YP_002154275.1 
 
YP_007238195.1 
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PA1P1_061A 36402 - 
36455 
42.6 17 hypothetical protein PB1_gp43 [Pseudomonas 
phage PB1] 
putative baseplate protein [Pseudomonas phage 
SN]  
3E-09 
 
2E-04
  
YP_002455973.1 
 
YP_002418850.1 
PA1P1_061B 36448 - 
37701 
57.9 417 hypothetical protein BrSP1_62 [Pseudomonas 
phage BrSP1] 
putative baseplate protein [Pseudomonas phage 
NH-4] 
0 
 
0 
ATI16244.1 
 
YP_007002590.1 
PA1P1_062 37698 - 
39212 
55.7 504 hypothetical protein I7A_045 [Pseudomonas 
phage NH-4] 
putative structural protein [Pseudomonas phage 
JG024] 
0 
 
0 
YP_007002591.1 
 
YP_006200809.1 
PA1P1_063 39217 - 
42105 
57.8 962 tail fibers protein [Pseudomonas phage NP3] 
putative tail fiber component [Pseudomonas 
phage NH-4] 
0 
0 
AMQ76163.1 
YP_007002592.1 
PA1P1_064 42107 -
42535 
58.3 142 hypothetical protein [Pseudomonas phage NP3] 
putative tail fiber component [Pseudomonas 
phage JG024]  
4E-98  
7E-97
  
AMQ76164.1 
YP_006200811.1 
PA1P1_065 42535 - 
43197 
60.5 220 lytic enzyme [Pseudomonas phage NP3] 
putative endolysin [Pseudomonas phage JG024] 
2E-161 
7E-161 
AMQ76165.1 
YP_006200812.1 
PA1P1_066c 43472 - 
43221 
51.2 83 hypothetical protein PP141_gp48 [Pseudomonas 
phage 14-1] 
hypothetical protein LMA2_gp47 [Pseudomonas 
phage LMA2] 
2E-50 
 
3E-50 
YP_002364356.1 
 
YP_002154281.1 
PA1P1_067c 44663 - 
43752 
56.6 303 DNA ligase [Pseudomonas phage phiKT28] 
putative DNA ligase [Pseudomonas phage JG024] 
0 
0 
AKJ71489.1 
YP_006200814.1 
PA1P1_068c 45272 - 
44718 
54.8 184 DNA binding protein [Pseudomonas phage DL68] 
hypothetical protein PJG24_051 [Pseudomonas 
phage JG024] 
1E-131 
9E-131 
YP_009215178.1 
YP_006200815.1 
PA1P1_069c 45874 - 
45269 
59.6 201 hypothetical protein ORF050 [Pseudomonas phage 
F8] 
hypothetical protein PP141_gp51 [Pseudomonas 
phage 14-1] 
3E-137 
 
6E-137 
YP_001294467.1 
 
YP_002364359.1 
PA1P1_070c 46827 - 
45928 
59.3 299 hypothetical protein PP141_gp52 [Pseudomonas 
phage 14-1] 
hypothetical protein [Pseudomonas phage DL68] 
0 
 
0 
YP_002364360.1 
 
YP_009215176.1 
PA1P1_071c 47536 - 
46916 
53.6 206 hypothetical protein vBPaeMLS1_79 
[Pseudomonas phage vB_PaeM_LS1] 
hypothetical protein SL1_50 [Pseudomonas phage 
SL1] 
3E-145 
 
1E-144 
AVJ48847.1 
 
AUS03325.1 
PA1P1_072c 49190 - 
47631 
55.2 519 putative helicase [Pseudomonas phage KPP12] 
putative DNA helicase [Pseudomonas phage 
vB_PaeM_CEB_DP1] 
0 
0 
YP_007238207.1 
AKP24441.1 
PA1P1_073c 49597 - 
49187 
55.2 136 hypothetical protein [Pseudomonas phage KPP12] 
putative DNA helicase [Pseudomonas phage NH-4] 
2E-94 
2E-94 
YP_007238208.1 
YP_007002602.1 
PA1P1_074c 52697 - 
49590 
55.0 1035 putative DNA polymerase [Pseudomonas phage 
KPP12] 
DNA polymerase III alpha subunit [Pseudomonas 
phage vB_PaeM_LS1] 
0 
 
0 
YP_007238209.1 
 
AVJ48844.1 
 
PA1P1_075c 53251 - 
52697 
53.3 184 putative DNA polymerase III epsilon subunit 
[Pseudomonas phage NH-4] 
putative DNA polymerase III, epsilon subunit 
[Pseudomonas phage LMA2] 
2E-135 
 
3E-135 
YP_007002604.1 
 
YP_002154290.1 
PA1P1_076c 54358 - 
53327 
58.4 343 putative 3'-phosphatase, 5'-polynucleotide kinase 
[Pseudomonas aeruginosa] 
putative polynucleotide kinase [Pseudomonas 
phage KPP12] 
0 
 
0 
SBT96767.1 
 
YP_007238211.1 
PA1P1_077c 54552 - 
54361 
48.4 63 hypothetical protein PJG24_060 [Pseudomonas 
phage JG024] 
hypothetical protein [Pseudomonas phage KPP12] 
3E-35 
 
1E-34 
YP_006200824.1 
 
YP_007238212.1 
PA1P1_078c 55471 - 
54554 
58.6 305 putative thymidylate synthase [Pseudomonas 
phage JG024] 
hypothetical protein PP141_gp60 [Pseudomonas 
phage 14-1] 
0 
 
0 
YP_006200825.1 
 
YP_002364368.1 
PA1P1_079c 55677 - 
55471 
52.2 68 hypothetical protein [Pseudomonas phage KPP12] 
hypothetical protein SL1_42 [Pseudomonas phage 
SL1] 
1E-40 
2E-40 
YP_007238214.1 
AUS03317.1 
PA1P1_080c 55951 - 
55685 
56.9 88 hypothetical protein [Pseudomonas phage PA5] 
hypothetical protein phiKT28_064 [Pseudomonas 
phage phiKT28] 
2E-56 
5E-56 
APD20761.1 
AKJ71502.1 
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PA1P1_081c 56169 - 
55951 
55.7 72 hypothetical protein PPSN_gp64 [Pseudomonas 
phage SN] 
hypothetical protein LMA2_gp62 [Pseudomonas 
phage LMA2] 
2E-46 
 
3E-46 
YP_002418870.1 
 
YP_002154296.1 
PA1P1_082c 56371 - 
56153 
59.8 72 hypothetical protein LBL3_gp61 [Pseudomonas 
phage LBL3] 
hypothetical protein [Pseudomonas phage KPP12] 
5E-43 
 
2E-42 
YP_002154206.1 
 
YP_007238217.1 
PA1P1_083c 56601 - 
56371 
58.9 76 hypothetical protein PP141_gp65 [Pseudomonas 
phage 14-1] 
hypothetical protein LBL3_gp62 [Pseudomonas 
phage LBL3] 
6E-50 
 
1E-49 
YP_002364373.1 
 
YP_002154207.1 
PA1P1_084c 57691 - 
56690 
56.2 333 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein vB_Pae_PS44_00069 
[Pseudomonas phage vB_Pae_PS44] 
0 
0 
YP_009215162.1 
YP_009211393.1 
PA1P1_085c 58680 - 
57796 
62.1 294 hypothetical protein PP141_gp67 [Pseudomonas 
phage 14-1] 
hypothetical protein [Pseudomonas phage DL68] 
0 
 
0 
YP_002364375.1 
 
YP_009215161.1 
PA1P1_086c 60029 - 
58842 
55.4 395 putative ATP-dependent exonuclease V 
[Pseudomonas phage SN] 
hypothetical protein ORF067 [Pseudomonas phage 
F8] 
0 
 
0 
YP_002418875.1 
 
YP_001294484.1 
PA1P1_087c 60438 - 
60016 
57.0 140 hypothetical protein ORF068 [Pseudomonas phage 
F8] 
hypothetical protein [Pseudomonas phage NP3] 
3E-98  
 
1E-97
  
YP_001294485.1 
 
AMQ76187.1 
PA1P1_088 60607 - 
61392 
59.2 261 hypothetical protein PP141_gp70 [Pseudomonas 
phage 14-1] 
hypothetical protein ORF069 [Pseudomonas phage 
F8] 
0 
 
0 
YP_002364378.1 
 
YP_001294486.1 
PA1P1_089 61403 - 
62626 
59.1 407 hypothetical protein vBPaeME215_00050 
[Pseudomonas phage vB_PaeM_E215] 
hypothetical protein LBL3_gp68 [Pseudomonas 
phage LBL3] 
0 
 
0 
ASZ72528.1 
 
YP_002154213.1 
PA1P1_090 62650 - 
63099 
58.2 149 hypothetical protein PP141_gp72 [Pseudomonas 
phage 14-1] 
hypothetical protein [Pseudomonas phage NP3] 
3E-105 
 
5E-105 
YP_002364380.1 
 
AMQ76190.1 
PA1P1_091 63096 - 
64172 
57.7 358 hypothetical protein [Pseudomonas phage DL52] 
hypothetical protein PP141_gp73 [Pseudomonas 
phage 14-1] 
0 
0 
AKF13701.1 
YP_002364381.1 
PA1P1_092 64178 - 
64363 
47.8 61 hypothetical protein ORF073 [Pseudomonas phage 
F8] 
hypothetical protein phiKT28_076 [Pseudomonas 
phage phiKT28] 
4E-33 
 
3E-32 
YP_001294490.1 
 
AKJ71514.1 
PA1P1_093 64511 - 
66250 
53.3 579 putative Ploop ATPase [Pseudomonas aeruginosa] 
virulence-associated protein E [Pseudomonas 
phage vB_Pae_PS44] 
0 
0 
SBT96795.1 
YP_009211402.1 
 
 
Table S5: Predicted genes of P. aeruginosa phage PA8P1. Homologs were achieved from BLASTp analyzes. 
Locus tag Position GC 
(%) 
Protein lenght 
(aa) 
Amino acid sequence identity/similarity to best homologs 
(% amino acid identity) 
E-value (BLAST) Accession no. 
PA8P1_001 601 - 1170 59.1 189 hypothetical protein PP141_gp76 [Pseudomonas phage 14-
1] 
hypothetical protein [Pseudomonas phage S12-1] 
4E-138 
 
1E-137 
YP_002364384.1 
 
BAU16489.1 
PA8P1_002c 1949 - 1338 54.7 203 hypothetical protein vBPaeME215_00056 [Pseudomonas 
phage vB_PaeM_E215] 
hypothetical protein PP141_gp77 [Pseudomonas phage 14-
1] 
3E-142 
 
6E-142 
ASZ72534.1 
 
YP_002364385.1 
PA8P1_003c 2834 - 2139 60.5 231 hypothetical protein PP141_gp78 [Pseudomonas phage 14-
1] 
hypothetical protein vBPaeME215_00057 [Pseudomonas 
phage vB_PaeM_E215] 
2E-166 
 
 
5E-166 
YP_002364386.1 
 
 
ASZ72535.1 
PA8P1_004c 3156 - 2845 56.1 103 hypothetical protein PP141_gp79 [Pseudomonas phage 14-
1] 
hypothetical protein vBPaeME217_00082 [Pseudomonas 
phage vB_PaeM_E217] 
1E-72 
 
6E-72 
YP_002364387.1 
 
ASZ72466.1 
PA8P1_005c 3427 - 3206 53.2 73 hypothetical protein I7A_082c [Pseudomonas phage NH-4] 
hypothetical protein PP141_gp80 [Pseudomonas phage 14-
1] 
2E-44 
5E-44 
YP_007002628.1 
YP_002364388.1 
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PA8P1_006c 3707 - 3483 54.7 74 hypothetical protein PPSN_gp83 [Pseudomonas phage SN] 
hypothetical protein LBL3_gp79 [Pseudomonas phage LBL3] 
4E-47 
2E-46 
YP_002418889.1 
YP_002154224.1 
PA8P1_007c 4099 - 3773 56.3 108 hypothetical protein PII10A_07 [Pseudomonas aeruginosa] 
hypothetical protein LBL3_gp80 [Pseudomonas phage LBL3] 
7E-74 
2E-73 
SBT96689.1 
YP_002154225.1 
PA8P1_008c 4744 - 4100 59.7 214 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein PJG24_088 [Pseudomonas phage 
JG024] 
2E-154 
4E-154 
YP_009215144.1 
YP_006200852.1 
PA8P1_009c 4985 - 4776 58.6 69 hypothetical protein [Pseudomonas aeruginosa] 
hypothetical protein [Pseudomonas phage 
vB_PaeM_PAO1_Ab27] 
7E-45 
7E-40 
WP_015994944.1 
YP_009124313.1 
PA8P1_010c 5197 - 4982 52.3 71 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein PJG24_090 [Pseudomonas phage 
JG024] 
7E-44 
3E-43 
YP_009215142.1 
YP_006200854.1 
PA8P1_011c 5394 - 5194 56.7 66 hypothetical protein [Pseudomonas phage KPP22] 
hypothetical protein vBPaeMDP1_0085 [Pseudomonas 
phage vB_PaeM_CEB_DP1] 
2E-39 
2E-39 
 
BAU20627.1 
AKP24472.1 
PA8P1_012c 5642 - 5391 51.6 83 hypothetical protein vBPaeME217_00092 [Pseudomonas 
phage vB_PaeM_E217] 
hypothetical protein I7A_091c [Pseudomonas phage NH-4] 
1E-53 
 
2E-53 
 
ASZ72476.1 
 
YP_007002637.1 
PA8P1_013c 5917 - 5729 54.5 62 hypothetical protein PJG24_093 [Pseudomonas phage 
JG024] 
hypothetical protein [Pseudomonas phage DL68] 
8E-36 
 
7E-35 
YP_006200857.1 
 
YP_009215139.1 
PA8P1_014c 6642 - 5920 55.6 240 hypothetical protein PJG24_094 [Pseudomonas phage 
JG024] 
hypothetical protein BrSP1_16 [Pseudomonas phage BrSP1] 
3E-166 
 
5E-165 
YP_006200858.1 
 
ATI16268.1 
PA8P1_015c 6963 - 6661 54.1 100 hypothetical protein vBPaeMDP1_0001 [Pseudomonas 
phage vB_PaeM_CEB_DP1]  
hypothetical protein PJG24_001 [Pseudomonas phage 
JG024] 
1E-63 
 
3E-63 
AKP24388.1 
 
YP_006200766.1 
PA8P1_016c 7192 - 7019 53.4 57 hypothetical protein PPSN_gp02 [Pseudomonas phage SN] 
hypothetical protein PII10A_17 [Pseudomonas aeruginosa] 
5E-34 
1E-33 
YP_002418808.1 
SBT96699.1 
PA8P1_017c 7389 - 7243 53.1 48 hypothetical protein PPSN_gp03 [Pseudomonas phage SN] 
hypothetical protein SAMN05216409_118116 
[Pseudomonas lutea] 
5E-23 
6E-13 
YP_002418809.1 
SER37912.1 
PA8P1_018 7437 - 7559 49.6 40 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein LBL3_gp01 [Pseudomonas phage LBL3] 
2E-19 
8E-13 
YP_009215134.1 
YP_002154146.1 
PA8P1_019 7564 - 8946 52.4 460 terminase large subunit [Pseudomonas phage DL68] 
large terminase protein [Pseudomonas phage 
vB_PaeM_E215] 
0 
0 
YP_009215133.1 
ASZ72553.1 
PA8P1_020c 9366 - 8983 59.1 127 hypothetical protein PP141_gp04 [Pseudomonas phage 14-
1] 
hypothetical protein [Pseudomonas phage NP3] 
3E-86 
 
7E-86 
YP_002364312.1 
 
AMQ76120.1 
PA8P1_021c 9581 - 9363 54.8 72 hypothetical protein [Pseudomonas aeruginosa] 
hypothetical protein [Pseudomonas phage NP3] 
4E-46 
3E-45 
WP_015994883.1 
AMQ76121.1 
PA8P1_022c 9931 - 9581 60.7 116 hypothetical protein LBL3_gp05 [Pseudomonas phage LBL3] 
hypothetical protein SL1_06 [Pseudomonas phage SL1] 
1E-78 
2E-76 
YP_002154150.1 
AUS03281.1 
PA8P1_023c 10373 - 
9975 
59.4 132 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein LBL3_gp06 [Pseudomonas phage LBL3] 
1E-87 
2E-86 
YP_009215129.1 
YP_002154151.1 
PA8P1_024c 11155 - 
10376 
57.2 259 hypothetical protein PP141_gp08 [Pseudomonas phage 14-
1] 
hypothetical protein [Pseudomonas phage DL68] 
0 
 
0 
YP_002364316.1 
 
YP_009215128.1 
PA8P1_025c 11679 - 
11242 
60.3 145 hypothetical protein vB_Pae436M-8_10 [Pseudomonas 
phage vB_Pae436M-8] 
hypothetical protein [Pseudomonas phage NP3] 
2E-98 
2E-97 
ANT44196.1 
AMQ76125.1 
PA8P1_026c 12283 - 
11696 
56.8 195 Phage protein [Pseudomonas phage S12-1] 
hypothetical protein LBL3_gp09 [Pseudomonas phage LBL3] 
6E-145 
1E-144 
BAU16423.1 
YP_002154154.1 
PA8P1_027c 12388 - 
12293 
51.0 31 hypothetical protein PP141_gp11 [Pseudomonas phage 14-
1] 
hypothetical protein LBL3_gp88 [Pseudomonas phage LBL3] 
2E-11 
 
3E-11 
YP_002364319.1 
 
YP_004221739.1 
PA8P1_028c 13317 - 
12385 
56.6 310 hypothetical protein PP141_gp12 [Pseudomonas phage 14-
1] 
hypothetical protein vBPaeME215_00085 [Pseudomonas 
phage vB_PaeM_E215] 
0 
 
0 
YP_002364320.1 
 
ASZ72563.1 
PA8P1_029c 13920 - 
13420 
56.3 166 hypothetical protein PP141_gp13 [Pseudomonas phage 14-
1] 
hypothetical protein PJG24_013 [Pseudomonas phage 
JG024] 
4E-120 
 
2E-119 
YP_002364321.1 
 
YP_006200778.1 
PA8P1_030c 14287 - 
13940 
54.0 115 hypothetical protein PP141_gp14 [Pseudomonas phage 14-
1] 
hypothetical protein [Pseudomonas phage DL68] 
9E-76 
 
1E-75 
YP_002364322.1 
 
YP_009215123.1 
PA8P1_031c 14847 - 
14536 
50.3 103 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein PJG24_015 [Pseudomonas phage 
JG024] 
4E-67 
3E-66 
YP_009215122.1 
YP_006200780.1 
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PA8P1_032c 15056 - 
14853 
56.4 67 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein PPGF8SP_0081 [Pseudomonas phage 
SPM-1] 
2E-39 
4E-37 
YP_009215121.1 
AHH02940.1 
PA8P1_033c 15376 - 
15053 
56.2 107 hypothetical protein vBPaeME215_00090 [Pseudomonas 
phage vB_PaeM_E215] 
hypothetical protein vB_Pae_PS44_00019 [Pseudomonas 
phage vB_Pae_PS44] 
9E-75 
 
5E-74 
ASZ72568.1 
 
YP_009211343.1 
PA8P1_034c 15808 - 
15407 
53.0 133 hypothetical protein vBPaeME215_00091 [Pseudomonas 
phage vB_PaeM_E215] 
hypothetical protein PP141_gp17 [Pseudomonas phage 14-
1] 
1E-92 
 
1E-91 
ASZ72569.1 
 
YP_002364325.1 
PA8P1_035 15988 - 
18285 
56.7 765 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein vBPaeME215_00092 [Pseudomonas 
phage vB_PaeM_E215] 
0 
0 
YP_009215210.1 
ASZ72570.1 
PA8P1_036 18285 - 
19121 
53.4 278 hypothetical protein PP141_gp19 [Pseudomonas phage 14-
1] 
putative minor head protein [Pseudomonas phage KPP12] 
0 
 
0 
YP_002364327.1 
 
YP_007238173.1 
PA8P1_037 19140 - 
19346 
55.1 68 hypothetical protein phiKT28_022 [Pseudomonas phage 
phiKT28] 
hypothetical protein vBPaeMDP1_0020 [Pseudomonas 
phage vB_PaeM_CEB_DP1] 
1E-41 
 
5E-41 
AKJ71460.1 
 
AKP24407.1 
PA8P1_038 19343 - 
19483 
53.2 46 hypothetical protein LMA2_gp20 [Pseudomonas phage 
LMA2] 
hypothetical protein BrSP1_38 [Pseudomonas phage BrSP1] 
2E-23 
 
9E-23 
YP_002154254.1 
 
ATI16221.1 
PA8P1_039 20035 - 
21429 
58.2 464 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein PP141_gp22 [Pseudomonas phage 14-
1] 
0 
0 
YP_009215206.1 
YP_002364330.1 
PA8P1_040 21433 - 
22068 
62.7 211 hypothetical protein PP141_gp23 [Pseudomonas phage 14-
1] 
structural protein [Pseudomonas phage SN] 
5E-148 
 
1E-147 
YP_002364331.1 
 
YP_002418830.1 
PA8P1_041 22078 - 
23226 
61.3 382 capsid and scaffold protein [Pseudomonas phage NP3] 
putative major structural protein [Pseudomonas phage 
vB_PaeM_CEB_DP1] 
0 
0 
AMQ76141.1 
AKP24411.1 
PA8P1_042 23328 - 
23765 
54.1 145 hypothetical protein PPSN_gp26 [Pseudomonas phage SN] 
hypothetical protein LBL3_gp22 [Pseudomonas phage LBL3] 
1E-103 
3E-103 
YP_002418832.1 
YP_002154167.1 
PA8P1_043 23780 - 
24247 
58.3 155 structural protein [Pseudomonas phage SN] 
hypothetical protein [Pseudomonas phage DL68] 
2E-109 
3E-109 
YP_002418833.1 
YP_009215202.1 
PA8P1_044 24244 - 
24642 
51.4 132 hypothetical protein [Pseudomonas phage NP3] 
structural protein [Pseudomonas phage SN] 
3E-92 
8E-92 
AMQ76144.1 
YP_002418834.1 
PA8P1_045 24650 - 
25201 
48.0 183 hypothetical protein LBL3_gp25 [Pseudomonas phage LBL3] 
hypothetical protein LMA2_gp27 [Pseudomonas phage 
LMA2] 
9E-133 
1E-132 
YP_002154170.1 
YP_002154261.1 
PA8P1_046 25198 - 
25779 
54.8 193 hypothetical protein ORF028 [Pseudomonas phage F8] 
hypothetical protein [Pseudomonas phage KPP12] 
3E-137 
1E-136 
YP_001294445.1 
YP_007238183.1 
PA8P1_047 25795 - 
27309 
59.5 504 hypothetical protein I7A_031 [Pseudomonas phage NH-4] 
hypothetical protein vBPaeMDP1_0030 [Pseudomonas 
phage vB_PaeM_CEB_DP1] 
0 
0 
YP_007002577.1 
AKP24417.1 
PA8P1_048 27368 - 
27820 
59.8 150 putative structural protein [Pseudomonas phage LMA2] 
structural protein [Pseudomonas phage phiKT28] 
2E-103 
2E-102 
YP_002154264.1 
AKJ71471.1 
PA8P1_049 27820 - 
28143 
54.6 107 putative structural protein [Pseudomonas phage LMA2] 
putative structural protein [Pseudomonas phage JG024] 
2E-75 
5E-75 
YP_002154265.1 
YP_006200797.1 
PA8P1_050 28140 - 
28490 
53.6 116 putative structural protein [Pseudomonas phage LMA2] 
structural protein [Pseudomonas phage SL1] 
3E-78 
1E-77 
YP_002154266.1 
AUS03345.1 
PA8P1_051 28492 - 
28923 
65.0 143 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein PPSN_gp35 [Pseudomonas phage SN] 
3E-92 
1E-91 
YP_009215194.1 
YP_002418841.1 
PA8P1_052 28933 - 
29436 
52.2 167 structural protein [Pseudomonas phage SN] 
putative structural protein [Pseudomonas phage LMA2] 
3E-115 
1E-114 
YP_002418842.1 
YP_002154268.1 
PA8P1_053 29436 - 
29975 
55.7 179 putative structural protein [Pseudomonas phage LMA2] 
putative structural protein [Pseudomonas phage LBL3] 
3E-127 
9E-127 
YP_002154269.1 
YP_002154178.1 
PA8P1_054 29984 - 
30577 
46.6 197 hypothetical protein vBPaeME217_00038 [Pseudomonas 
phage vB_PaeM_E217] 
putative structural protein [Pseudomonas phage KPP12] 
5E-140 
 
2E-139 
ASZ72422.1 
 
YP_007238190.1 
PA8P1_055 30587 - 
31015 
57.1 142 hypothetical protein LBL3_gp35 [Pseudomonas phage LBL3] 
hypothetical protein phiKTN6_037 [Pseudomonas phage 
phiKTN6] 
4E-101 
 
2E-100 
YP_002154180.1 
 
AKJ71569.1 
PA8P1_056 31019 - 
33595 
57.9 858 putative lytic tail protein [Pseudomonas phage LMA2] 
internal (core) protein [Pseudomonas phage NP3] 
0 
0 
YP_002154272.1 
AMQ76156.1 
PA8P1_057 33595 - 
34458 
51.7 287 putative structural protein [Pseudomonas phage LMA2] 
putative structural protein [Pseudomonas phage 
vB_PaeM_CEB_DP1] 
0 
0 
YP_002154273.1 
AKP24427.1 
PA8P1_058 34458 - 
34991 
47.8 177 hypothetical protein PP141_gp41 [Pseudomonas phage 14-
1] 
hypothetical protein [Pseudomonas phage DL68] 
2E-127 
 
5E-127 
YP_002364349.1 
 
YP_009215187.1 
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PA8P1_059 35047 - 
35712 
53.0 221 hypothetical protein LMA2_gp41 [Pseudomonas phage 
LMA2] 
putative baseplate [Pseudomonas phage KPP12] 
2E-160 
 
4E-160 
YP_002154275.1 
 
YP_007238195.1 
PA8P1_060A 35723 - 
35776 
42.6 17 hypothetical protein PB1_gp43 [Pseudomonas phage 
PB1] 
putative baseplate protein [Pseudomonas phage SN] 
3E-09 
 
2E-04
  
YP_002455973.1 
 
YP_002418850.1 
PA8P1_060B 35769 - 
37022 
57.7 417 putative structural protein [Pseudomonas phage LMA2] 
putative baseplate protein [Pseudomonas phage SN] 
0 
0 
YP_002154276.1 
YP_002418850.1 
PA8P1_061 37019 - 
38533 
56.0 504 hypothetical protein PP141_gp44 [Pseudomonas phage 14-
1] 
structural protein [Pseudomonas phage vB_Pae436M-8] 
0 
 
0 
YP_002364352.1 
 
ANT44230.1 
PA8P1_062 38538 - 
41426 
57.1 962 putative tail fiber component [Pseudomonas phage NH-4] 
tail fibers protein [Pseudomonas phage NP3] 
0 
0 
YP_007002592.1 
AMQ76163.1 
PA8P1_063 41428 - 
41856 
58.3 142 hypothetical protein [Pseudomonas phage NP3] 
putative tail fiber component [Pseudomonas phage JG024] 
9E-99 
2E-97 
AMQ76164.1 
YP_006200811.1 
PA8P1_064 41856 - 
42518 
60.5 220 lytic enzyme [Pseudomonas phage NP3] 
putative endolysin [Pseudomonas phage JG024] 
2E-161 
7E-161 
AMQ76165.1 
YP_006200812.1 
PA8P1_065c 42793 - 
42542 
51.2 83 hypothetical protein PP141_gp48 [Pseudomonas phage 14-
1] 
hypothetical protein LMA2_gp47 [Pseudomonas phage 
LMA2] 
2E-50 
 
3E-50 
YP_002364356.1 
 
YP_002154281.1 
PA8P1_066c 43984 - 
43073 
55.7 303 DNA ligase [Pseudomonas phage phiKT28] 
putative DNA ligase [Pseudomonas phage JG024] 
0 
0 
AKJ71489.1 
YP_006200814.1 
PA8P1_067c 44593 - 
44039 
54.4 184 DNA binding protein [Pseudomonas phage DL68] 
hypothetical protein PJG24_051 [Pseudomonas phage 
JG024] 
2E-132 
2E-131 
YP_009215178.1 
YP_006200815.1 
PA8P1_068c 45195 - 
44590 
60.2 201 hypothetical protein ORF050 [Pseudomonas phage F8] 
hypothetical protein PP141_gp51 [Pseudomonas phage 14-
1] 
4E-139 
9E-139 
YP_001294467.1 
YP_002364359.1 
PA8P1_069c 46148 - 
45249 
59.9 299 hypothetical protein PP141_gp52 [Pseudomonas phage 14-
1] 
hypothetical protein [Pseudomonas phage DL68] 
0 
 
0 
YP_002364360.1 
 
YP_009215176.1 
PA8P1_070c 46857 - 
46237 
53.3 206 hypothetical protein vBPaeMLS1_79 [Pseudomonas phage 
vB_PaeM_LS1] 
hypothetical protein SL1_50 [Pseudomonas phage SL1] 
3E-145 
 
1E-144 
AVJ48847.1 
 
AUS03325.1 
PA8P1_071c 48511 - 
46952 
55.1 519 hypothetical protein PPSN_gp55 [Pseudomonas phage SN] 
DNA helicase [Pseudomonas phage vB_Pae436M-8] 
0 
0 
YP_002418861.1 
ANT44241.1 
PA8P1_072c 48918 - 
48508 
55.2 136 hypothetical protein LBL3_gp52 [Pseudomonas phage LBL3] 
hypothetical protein [Pseudomonas phage NP3] 
6E-95 
6E-95 
YP_002154197.1 
AMQ76173.1 
PA8P1_073c 52018 - 
48911 
54.9 1035 hypothetical protein PP141_gp56 [Pseudomonas phage 14-
1] 
DNA polymerase III subunit alpha [Pseudomonas phage 
vB_Pae_PS44] 
0 
 
0 
YP_002364364.1 
 
YP_009211383.1 
PA8P1_074c 52572 - 
52018 
52.8 184 putative DNA polymerase III, epsilon subunit [Pseudomonas 
phage LMA2] 
putative DNA polymerase III epsilon subunit [Pseudomonas 
phage NH-4] 
3E-135 
 
3E-135 
YP_002154290.1 
 
YP_007002604.1 
PA8P1_075c 53679 - 
52648 
58.4 343 putative 3'-phosphatase, 5'-polynucleotide kinase 
[Pseudomonas aeruginosa] 
putative polynucleotide kinase [Pseudomonas phage 
KPP12] 
0 
 
0 
SBT96767.1 
 
YP_007238211.1 
PA8P1_076c 53873 - 
53682 
49.0 63 hypothetical protein PJG24_060 [Pseudomonas phage 
JG024] 
hypothetical protein [Pseudomonas phage KPP12] 
3E-35 
 
1E-34 
YP_006200824.1 
 
YP_007238212.1 
PA8P1_077c 54792 - 
53875 
58.1 305 hypothetical protein PP141_gp60 [Pseudomonas phage 14-
1] 
putative thymidylate synthase [Pseudomonas phage JG024] 
0 
 
0 
YP_002364368.1 
 
YP_006200825.1 
PA8P1_078c 54998 - 
54792 
50.1 68 hypothetical protein [Pseudomonas phage KPP12] 
hypothetical protein SL1_42 [Pseudomonas phage SL1] 
4E-41 
8E-41 
YP_007238214.1 
AUS03317.1 
PA8P1_079c 55236 - 
55006 
57.1 76 hypothetical protein PPSN_gp63 [Pseudomonas phage SN] 
hypothetical protein PP141_gp62 [Pseudomonas phage 14-
1] 
1E-47 
1E-47 
YP_002418869.1 
YP_002364370.1 
PA8P1_080c 55487 - 
55269 
54.8 72 hypothetical protein PPSN_gp64 [Pseudomonas phage SN] 
hypothetical protein LMA2_gp62 [Pseudomonas phage 
LMA2] 
2E-46 
3E-46 
YP_002418870.1 
YP_002154296.1 
PA8P1_081c 55689 - 
55471 
59.4 72 hypothetical protein LBL3_gp61 [Pseudomonas phage LBL3] 
hypothetical protein [Pseudomonas phage KPP12] 
2E-42 
6E-42 
YP_002154206.1 
YP_007238217.1 
PA8P1_082c 55919 - 
55689 
58.9 76 hypothetical protein PP141_gp65 [Pseudomonas phage 14-
1] 
hypothetical protein LBL3_gp62 [Pseudomonas phage LBL3] 
6E-50 
 
1E-49 
YP_002364373.1 
 
YP_002154207.1 
PA8P1_083c 57008 - 
56007 
55.6 333 hypothetical protein PP141_gp66 [Pseudomonas phage 14-
1] 
hypothetical protein PB1_gp68 [Pseudomonas phage PB1] 
0 
 
0 
YP_002364374.1 
 
YP_002455998.1 
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PA8P1_084c 58003 - 
57113 
63.2 296 hypothetical protein [Pseudomonas phage PA5] 
putative structural protein [Pseudomonas phage KPP12] 
1E-169 
2E-169 
APD20755.1 
YP_007238220.1 
PA8P1_085c 59351 - 
58164 
55.0 395 putative ATP-dependent exonuclease V [Pseudomonas 
phage SN] 
hypothetical protein ORF067 [Pseudomonas phage F8] 
0 
 
0 
YP_002418875.1 
 
YP_001294484.1 
PA8P1_086c 59760 - 
59338 
56.7 140 hypothetical protein ORF068 [Pseudomonas phage F8] 
hypothetical protein I7A_070c [Pseudomonas phage NH-4] 
1E-97 
3E-97 
YP_001294485.1 
YP_007002616.1 
PA8P1_087 59929 - 
60714 
59.0 261 hypothetical protein LMA2_gp69 [Pseudomonas phage 
LMA2] 
hypothetical protein vBPaeMLS1_62 [Pseudomonas phage 
vB_PaeM_LS1] 
0 
 
0 
YP_002154303.1 
 
AVJ48831.1 
PA8P1_088 60725 - 
61726 
57.6 333 hypothetical protein [Pseudomonas aeruginosa] 
hypothetical protein vB_Pae436M-8_72 [Pseudomonas 
phage vB_Pae436M-8] 
2E-92 
5E-77 
WP_051488611.1 
ANT44258.1 
PA8P1_089 61726 - 
62175 
58.2 149 hypothetical protein [Pseudomonas phage DL60] 
hypothetical protein [Pseudomonas phage NP3] 
7E-104 
9E-103 
YP_009193759.1 
AMQ76190.1 
PA8P1_090 62172 - 
63248 
57.5 358 hypothetical protein PP141_gp73 [Pseudomonas phage 14-
1] 
hypothetical protein vBPaeMLS1_59 [Pseudomonas phage 
vB_PaeM_LS1] 
0 
 
0 
YP_002364381.1 
 
AVJ48828.1 
PA8P1_091 63254 - 
63439 
50.5 61 hypothetical protein LMA2_gp73 [Pseudomonas phage 
LMA2]  
hypothetical protein PPSN_gp75 [Pseudomonas phage SN] 
9E-34 
 
2E-33 
YP_002154307.1 
 
YP_002418881.1 
PA8P1_092 63587 - 
65326 
53.3 579 putative Ploop ATPase [Pseudomonas aeruginosa] 
virulence-associated protein E [Pseudomonas phage 
vB_Pae_PS44] 
0 
0 
SBT96795.1 
YP_009211402.1 
 
 
Table S6: Predicted genes of P. aeruginosa phage PA11P1. Homologs were achieved from BLASTp analyzes. 
Locus tag Position GC 
(%) 
Protein 
lenght (aa) 
Amino acid sequence identity/similarity to best 
homologs (% amino acid identity) 
E-value (BLAST) Accession no. 
PA11P1_001 604 - 1173 58.9 189 hypothetical protein [Pseudomonas phage 
vB_PaeM_PAO1_Ab27] 
hypothetical protein LMA2_gp76 [Pseudomonas 
phage LMA2] 
5E-138 
 
5E-137 
YP_009124304.1 
 
YP_002154309.1 
PA11P1_002c 1952 - 
1341 
55.1 203 hypothetical protein vBPaeME215_00056 
[Pseudomonas phage vB_PaeM_E215] 
hypothetical protein PP141_gp77 [Pseudomonas 
phage 14-1] 
2E-143 
 
5E-143 
ASZ72534.1 
 
YP_002364385.1 
PA11P1_003c 2828 - 
2142 
60.0 228 hypothetical protein PP141_gp78 [Pseudomonas 
phage 14-1] 
hypothetical protein vBPaeME215_00057 
[Pseudomonas phage vB_PaeM_E215] 
3E-157 
 
1E-156 
YP_002364386.1 
 
ASZ72535.1 
PA11P1_004c 3150 - 
2839 
55.8 103 hypothetical protein vBPaeMDP1_0076 
[Pseudomonas phage vB_PaeM_CEB_DP1] 
hypothetical protein BrSP1_5 [Pseudomonas phage 
BrSP1] 
1E-71 
 
4E-71 
AKP24463.1 
 
ATI16257.1 
PA11P1_005c 3424 - 
3203 
52.7 73 hypothetical protein PP141_gp80 [Pseudomonas 
phage 14-1] 
hypothetical protein I7A_082c [Pseudomonas phage 
NH-4] 
3E-44 
 
5E-44 
YP_002364388.1 
 
YP_007002628.1 
PA11P1_006c 3688 - 
3434 
56.9 84 hypothetical protein PP141_gp81 [Pseudomonas 
phage 14-1] 
hypothetical protein [Pseudomonas phage KPP22] 
1E-53 
 
5E-49 
YP_002364389.1 
 
BAU20633.1 
PA11P1_007c 3966 - 
3742 
55.6 74 hypothetical protein LBL3_gp79 [Pseudomonas 
phage LBL3] 
hypothetical protein PPSN_gp83 [Pseudomonas 
phage SN] 
3E-47 
 
2E-46 
YP_002154224.1 
 
YP_002418889.1 
PA11P1_008c 4358 - 
4032 
56.3 108 hypothetical protein PII10A_07 [Pseudomonas 
aeruginosa] 
hypothetical protein LBL3_gp80 [Pseudomonas 
phage LBL3] 
7E-74 
 
 
2E-73 
SBT96689.1 
 
 
YP_002154225.1 
PA11P1_009c 5003 - 
4359 
59.7 214 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein PJG24_088 [Pseudomonas 
phage JG024] 
2E-154 
4E-154 
YP_009215144.1 
YP_006200852.1 
PA11P1_010c 5244 - 
5035 
58.6 69 hypothetical protein [Pseudomonas aeruginosa] 
hypothetical protein [Pseudomonas phage 
vB_PaeM_PAO1_Ab27] 
7E-45 
7E-40 
WP_015994944.1 
YP_009124313.1 
PA11P1_011c 5456 - 
5241 
52.3 71 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein PJG24_090 [Pseudomonas 
phage JG024] 
7E-44 
3E-43 
YP_009215142.1 
YP_006200854.1 
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PA11P1_012c 5653 - 
5453 
56.7 66 hypothetical protein [Pseudomonas phage KPP22] 
hypothetical protein vBPaeMDP1_0085 
[Pseudomonas phage vB_PaeM_CEB_DP1] 
2E-39 
2E-39 
BAU20627.1 
BAU16501.1 
PA11P1_013c 5901 - 
5650 
51.6 83 hypothetical protein vBPaeME217_00092 
[Pseudomonas phage vB_PaeM_E217] 
hypothetical protein I7A_091c [Pseudomonas phage 
NH-4] 
1E-53 
 
2E-53 
ASZ72476.1 
 
YP_007002637.1 
PA11P1_014c 6176 - 
5988 
54.5 62 hypothetical protein PJG24_093 [Pseudomonas 
phage JG024] 
hypothetical protein [Pseudomonas phage DL68] 
8E-36 
 
7E-35 
YP_006200857.1 
 
YP_009215139.1 
PA11P1_015c 6865 - 
6179 
55.7 228 hypothetical protein PJG24_094 [Pseudomonas 
phage JG024] 
hypothetical protein BrSP1_16 [Pseudomonas phage 
BrSP1] 
3E-166 
 
5E-165 
YP_006200858.1 
 
ATI16268.1 
PA11P1_016c 7222 - 
6920 
54.1 100 hypothetical protein vBPaeMDP1_0001 
[Pseudomonas phage vB_PaeM_CEB_DP1] 
hypothetical protein PJG24_001 [Pseudomonas 
phage JG024] 
1E-63 
 
3E-63 
AKP24388.1 
 
YP_006200766.1 
PA11P1_017c 7451 - 
7278 
53.4 57 hypothetical protein PPSN_gp02 [Pseudomonas 
phage SN] 
hypothetical protein PII10A_17 [Pseudomonas 
aeruginosa] 
5E-34 
 
1E-33 
YP_002418808.1 
 
SBT96699.1 
PA11P1_018c 7648 - 
7502 
53.1 48 hypothetical protein PPSN_gp03 [Pseudomonas 
phage SN] 
hypothetical protein SAMN05216409_118116 
[Pseudomonas lutea] 
6E-23 
 
6E-13 
YP_002418809.1 
 
SER37912.1 
PA11P1_019 7823 - 
9205 
52.4 460 terminase large subunit [Pseudomonas phage DL68] 
large terminase protein [Pseudomonas phage 
vB_PaeM_E215] 
0 
0 
YP_009215133.1 
ASZ72553.1 
PA11P1_020c 9625 - 
9242 
59.1 127 hypothetical protein PP141_gp04 [Pseudomonas 
phage 14-1] 
hypothetical protein [Pseudomonas phage NP3] 
3E-86 
 
7E-86 
YP_002364312.1 
 
AMQ76120.1 
PA11P1_021c 9840 - 
9622 
54.8 72 hypothetical protein [Pseudomonas aeruginosa] 
hypothetical protein [Pseudomonas phage NP3] 
4E-46 
3E-45 
WP_015994883.1  
AMQ76121.1 
PA11P1_022c 10190 - 
9840 
60.7 116 hypothetical protein LBL3_gp05 [Pseudomonas 
phage LBL3] 
hypothetical protein SL1_06 [Pseudomonas phage 
SL1] 
1E-78 
 
2E-76 
YP_002154150.1 
 
AUS03281.1 
PA11P1_023c 10632 - 
10234 
59.4 132 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein LBL3_gp06 [Pseudomonas 
phage LBL3] 
1E-87 
2E-86 
YP_009215129.1 
YP_002154151.1 
PA11P1_024c 11414 - 
10635 
57.2 259 hypothetical protein PP141_gp08 [Pseudomonas 
phage 14-1] 
hypothetical protein [Pseudomonas phage DL68] 
0 
 
0 
YP_002364316.1 
 
YP_009215128.1 
PA11P1_025c 11938 - 
11501 
60.3 145 hypothetical protein vB_Pae436M-8_10 
[Pseudomonas phage vB_Pae436M-8] 
hypothetical protein [Pseudomonas phage NP3] 
2E-98 
 
2E-97 
ANT44196.1 
 
AMQ76125.1 
PA11P1_026c 12542 - 
11955 
56.8 195 Phage protein [Pseudomonas phage S12-1] 
hypothetical protein LBL3_gp09 [Pseudomonas 
phage LBL3] 
6E-145 
1E-144 
BAU16423.1 
YP_002154154.1 
PA11P1_027c 12647 - 
12552 
51.0 31 hypothetical protein PP141_gp11 [Pseudomonas 
phage 14-1] 
hypothetical protein LBL3_gp88 [Pseudomonas 
phage LBL3] 
2E-11 
 
3E-11 
YP_002364319.1 
 
YP_004221739.1 
PA11P1_028c 13576 - 
12644 
56.6 310 hypothetical protein PP141_gp12 [Pseudomonas 
phage 14-1] 
hypothetical protein vBPaeME215_00085 
[Pseudomonas phage vB_PaeM_E215] 
0 
 
0 
YP_002364320.1 
 
ASZ72563.1 
PA11P1_029c 14179 - 
13679 
56.3 166 hypothetical protein PP141_gp13 [Pseudomonas 
phage 14-1] 
hypothetical protein PJG24_013 [Pseudomonas 
phage JG024] 
4E-120 
 
1E-119 
YP_002364321.1 
 
YP_006200778.1 
PA11P1_030c 14546 - 
14199 
54.0 115 hypothetical protein PP141_gp14 [Pseudomonas 
phage 14-1] 
hypothetical protein [Pseudomonas phage DL68]  
9E-76 
 
1E-75 
YP_002364322.1 
 
YP_009215123.1 
PA11P1_031c 15106 - 
14795 
50.3 103 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein PJG24_015 [Pseudomonas 
phage JG024] 
4E-67 
3E-66 
YP_009215122.1 
YP_006200780.1 
PA11P1_032c 15315 - 
15112 
56.4 67 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein PPGF8SP_0081 [Pseudomonas 
phage SPM-1] 
2E-39 
4E-37 
YP_009215121.1 
AHH02940.1 
PA11P1_033c 15635 - 
15312 
56.2 107 hypothetical protein vBPaeME215_00090 
[Pseudomonas phage vB_PaeM_E215] 
hypothetical protein vB_Pae_PS44_00019 
[Pseudomonas phage vB_Pae_PS44] 
9E-75 
 
5E-74 
ASZ72568.1 
 
YP_009211343.1 
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PA11P1_034c 16067 - 
15666 
53.0 133 hypothetical protein vBPaeME215_00091 
[Pseudomonas phage vB_PaeM_E215] 
hypothetical protein PP141_gp17 [Pseudomonas 
phage 14-1] 
1E-92 
 
1E-91 
ASZ72569.1 
 
YP_002364325.1 
PA11P1_035 16247 - 
18544 
56.8 729 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein vBPaeME215_00092 
[Pseudomonas phage vB_PaeM_E215] 
0 
0 
YP_009215210.1 
ASZ72570.1 
PA11P1_036 18544 - 
19380 
53.4 278 putative minor head protein [Pseudomonas phage 
SN] 
putative minor head protein [Pseudomonas phage 
SL1] 
0 
 
0 
YP_002418826.1 
 
AUS03359.1 
PA11P1_037 19399 - 
19605 
55.6 68 hypothetical protein PPSN_gp21 [Pseudomonas 
phage SN] 
hypothetical protein LBL3_gp17 [Pseudomonas 
phage LBL3] 
2E-41 
 
6E-40 
YP_002418827.1 
 
YP_002154162.1 
PA11P1_038 19602 - 
19742 
53.2 46 hypothetical protein PPSN_gp22 [Pseudomonas 
phage SN] 
hypothetical protein PJG24_021 [Pseudomonas 
phage JG024] 
4E-23 
 
3E-22 
YP_002418828.1 
 
YP_006200786.1 
PA11P1_039 20296 - 
21690 
58.3 464 hypothetical protein [Pseudomonas phage DL68] 
hypothetical protein PP141_gp22 [Pseudomonas 
phage 14-1] 
0 
0 
YP_009215206.1 
YP_002364330.1 
PA11P1_040 21694 - 
22329 
62.6 211 hypothetical protein PP141_gp23 [Pseudomonas 
phage 14-1] 
structural protein [Pseudomonas phage SN] 
5E-148 
 
1E-147 
YP_002364331.1 
 
YP_002418830.1 
PA11P1_041 22339 - 
23487 
61.0 382 putative major structural protein [Pseudomonas 
phage vB_PaeM_CEB_DP1] 
hypothetical protein PP141_gp24 [Pseudomonas 
phage 14-1] 
0 
 
0 
AKP24411.1 
 
YP_002364332.1 
PA11P1_042 23589 - 
24026 
55.0 145 hypothetical protein vBPaeMDP1_0025 
[Pseudomonas phage vB_PaeM_CEB_DP1] 
hypothetical protein [Pseudomonas phage KPP12] 
6E-104 
 
2E-103 
AKP24412.1 
 
YP_007238179.1 
PA11P1_043 24041 - 
24508 
59.2 155 putative structural protein [Pseudomonas phage 
KPP12] 
structural protein [Pseudomonas phage phiKTN6] 
4E-110 
 
1E-109 
YP_007238180.1 
 
AKJ71557.1 
PA11P1_044 24505 - 
24903 
52.1 132 putative structural protein [Pseudomonas phage 
KPP12] 
structural protein [Pseudomonas phage phiKTN6] 
2E-91 
 
6E-91 
YP_007238181.1 
 
AKJ71558.1 
PA11P1_045 24911 - 
25462 
48.6 183 hypothetical protein [Pseudomonas phage KPP12] 
hypothetical protein vB_Pae_PS44_00031 
[Pseudomonas phage vB_Pae_PS44] 
3E-133 
5E-133 
YP_007238182.1 
YP_009211355.1 
PA11P1_046 25459 - 
26040 
54.8 193 hypothetical protein ORF028 [Pseudomonas phage 
F8] 
hypothetical protein [Pseudomonas phage KPP12] 
3E-137 
 
1E-136 
YP_001294445.1 
 
YP_007238183.1 
PA11P1_047 26056 - 
27570 
59.1 504 hypothetical protein I7A_031 [Pseudomonas phage 
NH-4] 
hypothetical protein vBPaeMDP1_0030 
[Pseudomonas phage vB_PaeM_CEB_DP1] 
0 
 
0 
YP_007002577.1 
 
AKP24417.1 
PA11P1_048 27629 - 
28081 
59.6 150 putative structural protein [Pseudomonas phage 
LMA2] 
structural protein [Pseudomonas phage phiKT28] 
2E-103 
 
2E-102 
YP_002154264.1 
 
AKJ71471.1 
PA11P1_049 28081 - 
28404 
54.6 107 putative structural protein [Pseudomonas phage 
LMA2] 
putative structural protein [Pseudomonas phage 
JG024] 
2E-75 
 
5E-75 
YP_002154265.1 
 
YP_006200797.1 
PA11P1_050 28401 - 
28751 
53.0 116 putative structural protein [Pseudomonas phage 
LMA2] 
structural protein [Pseudomonas phage SL1] 
3E-78 
 
1E-77 
YP_002154266.1 
 
AUS03345.1 
PA11P1_051 28753 - 
29184 
64.1 143 hypothetical protein PPSN_gp35 [Pseudomonas 
phage SN] 
hypothetical protein PII10A_51 [Pseudomonas 
aeruginosa] 
8E-93 
 
2E-92 
YP_002418841.1 
 
SBT96733.1 
PA11P1_052 29194 - 
29697 
52.2 167 structural protein [Pseudomonas phage SN] 
putative structural protein [Pseudomonas phage 
LMA2] 
3E-115 
 
1E-114 
YP_002418842.1 
 
YP_002154268.1 
PA11P1_053 29697 - 
30236 
51.1 179 putative structural protein [Pseudomonas phage 
LMA2] 
putative structural protein [Pseudomonas phage 
LBL3] 
5E-128 
 
2E-127 
YP_002154269.1 
 
YP_002154178.1 
PA11P1_054 30245 - 
30838 
46.8 197 putative structural protein [Pseudomonas phage 
KPP12] 
hypothetical protein vBPaeME217_00038 
[Pseudomonas phage vB_PaeM_E217] 
3E-140 
 
2E-139 
YP_007238190.1 
 
ASZ72422.1 
PA11P1_055 30848 - 
31276 
57.1 142 hypothetical protein LBL3_gp35 [Pseudomonas 
phage LBL3] 
4E-101 
 
YP_002154180.1 
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hypothetical protein phiKTN6_037 [Pseudomonas 
phage phiKTN6] 
2E-100 AKJ71569.1 
PA11P1_056 31280 - 
33856 
58.2 858 putative lytic tail protein [Pseudomonas phage 
LMA2] 
internal (core) protein [Pseudomonas phage NP3] 
0 
 
0 
YP_002154272.1 
 
AMQ76156.1 
PA11P1_057 33856 - 
34719 
52.1 287 putative structural protein [Pseudomonas phage 
LMA2] 
putative structural protein [Pseudomonas phage 
vB_PaeM_CEB_DP1] 
0 
 
0 
YP_002154273.1 
 
AKP24427.1 
PA11P1_058 34719 - 
35252 
48.3 177 hypothetical protein PP141_gp41 [Pseudomonas 
phage 14-1] 
hypothetical protein [Pseudomonas phage DL68] 
2E-127 
 
5E-127 
YP_002364349.1 
 
YP_009215187.1 
PA11P1_059 35308 - 
35973 
53 221 putative baseplate protein [Pseudomonas phage 
JG024] 
baseplate protein [Pseudomonas phage phiKTN6] 
5E-71 
 
6E-71 
YP_006200807.1 
 
AKJ71573.1 
PA11P1_060A 35984 - 
36037 
42.6 17 hypothetical protein PB1_gp43 [Pseudomonas 
phage PB1] 
putative baseplate protein [Pseudomonas phage 
SN] 
3E-09 
 
2E-04
  
YP_002455973.1 
 
YP_002418850.1 
PA11P1_060B 36030 - 
37283 
57.8 417 putative baseplate protein [Pseudomonas phage NH-
4] 
hypothetical protein BrSP1_62 [Pseudomonas phage 
BrSP1] 
0 
 
0 
YP_007002590.1 
 
ATI16244.1 
PA11P1_061 37280 - 
38794 
55.7 504 hypothetical protein I7A_045 [Pseudomonas phage 
NH-4] 
putative structural protein [Pseudomonas phage 
JG024] 
0 
 
0 
YP_007002591.1 
 
YP_006200809.1 
PA11P1_062 38799 - 
41687 
57.8 962 tail fibers protein [Pseudomonas phage NP3] 
putative tail fiber component [Pseudomonas phage 
NH-4] 
0 
0 
AMQ76163.1 
YP_007002592.1 
PA11P1_063 41689 - 
42117 
58.3 142 hypothetical protein [Pseudomonas phage NP3] 
putative tail fiber component [Pseudomonas phage 
JG024] 
4E-98 
6E-97 
AMQ76164.1 
YP_006200811.1 
PA11P1_064 42117 - 
42779 
60.5 220 lytic enzyme [Pseudomonas phage NP3] 
putative endolysin [Pseudomonas phage JG024] 
2E-161 
7E-161 
AMQ76165.1 
YP_006200812.1 
PA11P1_065c 43054 - 
42803 
51.2 83 hypothetical protein PP141_gp48 [Pseudomonas 
phage 14-1] 
hypothetical protein LMA2_gp47 [Pseudomonas 
phage LMA2] 
2E-50 
 
3E-50 
YP_002364356.1 
 
YP_002154281.1 
PA11P1_066c 44245 - 
43334 
56.6 303 DNA ligase [Pseudomonas phage phiKT28] 
putative DNA ligase [Pseudomonas phage JG024] 
0 
0 
AKJ71489.1 
YP_006200814.1 
PA11P1_067c 44854 - 
44300 
54.4 184 DNA binding protein [Pseudomonas phage DL68] 
hypothetical protein PJG24_051 [Pseudomonas 
phage JG024] 
2E-132 
2E-131 
YP_009215178.1 
YP_006200815.1 
PA11P1_068c 45456 - 
44851 
60.2 201 hypothetical protein ORF050 [Pseudomonas phage 
F8] 
hypothetical protein PP141_gp51 [Pseudomonas 
phage 14-1] 
4E-139 
 
9E-139 
YP_001294467.1 
 
YP_002364359.1 
PA11P1_069c 46409 - 
45510 
59.9 299 hypothetical protein PP141_gp52 [Pseudomonas 
phage 14-1] 
hypothetical protein [Pseudomonas phage DL68] 
0 
 
0 
YP_002364360.1 
 
YP_009215176.1 
PA11P1_070c 47118 - 
46498 
53.3 206 hypothetical protein vBPaeMLS1_79 [Pseudomonas 
phage vB_PaeM_LS1] 
hypothetical protein SL1_50 [Pseudomonas phage 
SL1] 
3E-145 
 
1E-144 
AVJ48847.1 
 
AUS03325.1 
PA11P1_071c 48772 - 
47213 
55.1 519 hypothetical protein PPSN_gp55 [Pseudomonas 
phage SN] 
DNA helicase [Pseudomonas phage vB_Pae436M-8] 
0 
 
0 
YP_002418861.1 
 
ANT44241.1 
PA11P1_072c 49179 - 
48769 
55.2 136 hypothetical protein LBL3_gp52 [Pseudomonas 
phage LBL3] 
hypothetical protein [Pseudomonas phage NP3] 
6E-95 
 
6E-95 
YP_002154197.1 
 
AMQ76173.1 
PA11P1_073c 52279 - 
49172 
54.9 1035 hypothetical protein PP141_gp56 [Pseudomonas 
phage 14-1] 
DNA polymerase III subunit alpha [Pseudomonas 
phage vB_Pae_PS44] 
0 
 
0 
YP_002364364.1 
 
YP_009211383.1 
PA11P1_074c 52833 - 
52279 
52.6 184 putative DNA polymerase III, epsilon subunit 
[Pseudomonas phage LMA2] 
putative DNA polymerase III epsilon subunit 
[Pseudomonas phage NH-4] 
3E-135 
 
3E-135 
YP_002154290.1 
 
YP_007002604.1 
PA11P1_075c 53940 - 
52909 
58.4 343 putative 3'-phosphatase, 5'-polynucleotide kinase 
[Pseudomonas aeruginosa] 
putative polynucleotide kinase [Pseudomonas phage 
KPP12] 
0 
 
0 
SBT96767.1 
 
YP_007238211.1 
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PA11P1_076c 54134 - 
53943 
48.4 63 hypothetical protein PJG24_060 [Pseudomonas 
phage JG024] 
hypothetical protein [Pseudomonas phage KPP12] 
3E-35 
 
1E-34 
YP_006200824.1 
 
YP_007238212.1 
PA11P1_077c 55053 - 
54136 
58.6 305 putative thymidylate synthase [Pseudomonas phage 
JG024] 
hypothetical protein PP141_gp60 [Pseudomonas 
phage 14-1] 
0 
 
0 
YP_006200825.1 
 
YP_002364368.1 
PA11P1_078c 55259 - 
55053 
51.2 68 hypothetical protein [Pseudomonas phage KPP12] 
hypothetical protein SL1_42 [Pseudomonas phage 
SL1] 
4E-41 
8E-41 
YP_007238214.1 
AUS03317.1 
PA11P1_079c 55533 - 
55267 
56.9 88 hypothetical protein [Pseudomonas phage PA5] 
hypothetical protein phiKT28_064 [Pseudomonas 
phage phiKT28] 
2E-56 
5E-56 
APD20761.1 
AKJ71502.1 
PA11P1_080c 55751 - 
55533 
55.7 72 hypothetical protein PPSN_gp64 [Pseudomonas 
phage SN] 
hypothetical protein LMA2_gp62 [Pseudomonas 
phage LMA2] 
2E-46 
 
3E-46 
YP_002418870.1 
 
YP_002154296.1 
PA11P1_081c 55953 - 
55735 
59.8 72 hypothetical protein LBL3_gp61 [Pseudomonas 
phage LBL3] 
hypothetical protein [Pseudomonas phage KPP12] 
5E-43 
 
2E-42 
YP_002154206.1 
 
YP_007238217.1 
PA11P1_082c 56183 - 
55953 
59.7 76 hypothetical protein PP141_gp65 [Pseudomonas 
phage 14-1] 
hypothetical protein LBL3_gp62 [Pseudomonas 
phage LBL3] 
6E-50 
 
1E-49 
YP_002364373.1 
 
YP_002154207.1 
PA11P1_083c 57272 - 
56271 
56.2 333 hypothetical protein [Pseudomonas phage NP3] 
hypothetical protein PPSN_gp67 [Pseudomonas 
phage SN] 
0 
0 
AMQ76184.1 
YP_002418873.1 
PA11P1_084c 58117 - 
57377 
61.7 246 hypothetical protein [Pseudomonas phage NP3] 
putative structural protein [Pseudomonas phage 
LMA2] 
2E-161 
4E-94 
AMQ76185.1 
YP_002154300.1 
PA11P1_085c 59466 - 
58279 
55.3 395 hypothetical protein LBL3_gp65 [Pseudomonas 
phage LBL3] 
putative ATP-dependent exonuclease V 
[Pseudomonas phage SN] 
0 
 
0 
YP_002154210.1 
 
YP_002418875.1 
PA11P1_086c 59,875 - 
59453 
56.7 140 hypothetical protein ORF068 [Pseudomonas 
phage F8] 
hypothetical protein [Pseudomonas phage NP3] 
3E-98  
 
1E-97
  
YP_001294485.1 
 
AMQ76187.1 
PA11P1_087 60044 - 
60829 
58.8 261 hypothetical protein ORF069 [Pseudomonas phage 
F8] 
hypothetical protein PPSN_gp71 [Pseudomonas 
phage SN] 
0 
 
0 
YP_001294486.1 
 
YP_002418877.1 
PA11P1_088 60840 - 
62063 
59.1 407 hypothetical protein vBPaeME215_00050 
[Pseudomonas phage vB_PaeM_E215] 
hypothetical protein LBL3_gp68 [Pseudomonas 
phage LBL3] 
0 
 
0 
ASZ72528.1 
 
YP_002154213.1 
PA11P1_089 62087 - 
62536 
58.2 149 hypothetical protein PP141_gp72 [Pseudomonas 
phage 14-1] 
hypothetical protein [Pseudomonas phage NP3] 
3E-105 
 
5E-105 
YP_002364380.1 
 
AMQ76190.1 
PA11P1_090 62533 - 
63609 
57.5 358 hypothetical protein [Pseudomonas phage DL52] 
hypothetical protein PP141_gp73 [Pseudomonas 
phage 14-1] 
0 
0 
AKF13701.1 
YP_002364381.1 
PA11P1_091 63615 - 
63800 
47.8 61 hypothetical protein ORF073 [Pseudomonas phage 
F8] 
hypothetical protein phiKT28_076 [Pseudomonas 
phage phiKT28] 
3E-33 
 
3E-32 
YP_001294490.1 
 
AKJ71514.1 
PA11P1_092 63948 - 
65687 
53.3 579 putative Ploop ATPase [Pseudomonas aeruginosa] 
virulence-associated protein E [Pseudomonas phage 
vB_Pae_PS44] 
0 
0 
SBT96795.1 
YP_009211402.1 
 
Table S7: Summarized results of the host range screenings. See also Fig. S1 for details. 
Pseudomonas aeruginosa strain access number PA1P1 PA8P1 PA11P1 fHo-Pae01 
5513 + - - - 
5514 +/- - +/- - 
5525 + + + + 
5537 + +/- + - 
5538 - - - - 
5539 + +/- + +/- 
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5548 - - - - 
5550 + + + + 
5551 - - - - 
5553 - - - - 
5668 + +/- +/- - 
5669 + + + + 
5670 +/- - +/- - 
5671 + + + + 
5672 + + + +/- 
5740 - - - - 
5741 + + + + 
5742 + - + - 
5743 + + + + 
5745 + + + + 
5746 + - + - 
5747 + + + - 
5826 + + + + 
5827 + + + + 
5828 + + + +/- 
5829 +/- - + - 
5831 + + + - 
5832 - - - - 
5833 + + + + 
5834 + + + + 
5835 + + + + 
5836 + + + - 
5837 + + + +/- 
5838 + + + - 
5839 + + + - 
5840 - - - - 
5841 - - - - 
5842 - - - - 
5844 - - - - 
5845 - - - - 
5846 + + + + 
5847 + - + - 
5848 + - +/- +/- 
PA1 (6327) + +/- + - 
PA8 (6329) + + + + 
PA11 (6331) + + + - 
6663 + + + - 
In each well, 190 Pl of 1:40 dilution of the host bacteria overnight culture was mixed with 10 Pl lysate (109 pfu/ml) of 
one of the phages. 
+ : infection was observed, - : no infection, +/- : partial infection 
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Fig. S1. A representative image of the evaluation of the host range screening results in Table S5.  
+ : infection was observed, - : no infection, +/- : partial infection. 
 
 
Fig. S2. Linear gradient purification of phage fHo-Pae01. The peak predicted to contain the phage is indicated with an 
arrow. Buffer A (20 mM Tris-Cl, pH 8.5), buffer B (20 mM Tris-Cl, 1M NaCl, pH 8.5) 
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Fig. S3. Step-gradient purification of phage fHo-Pae01. The peak predicted to contain the phage is indicated with an 
arrow. Fractions G7 and G8 were harvested. Buffer A: 20 mM Tris-Cl, pH 8.5; buffer B: 20 mM Tris-Cl, 1M NaCl, pH 8.5. 
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